_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
717911530,5/9/2015 17:20:31,1633275059,5/9/2015 17:20:02,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PRIMARY HYPERPARATHYROIDISM also seen in patients with MEN2A,n/a,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 17:21:35,1633275430,5/9/2015 17:19:46,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],HYPERPARATHYROIDISM,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 18:24:36,1633299030,5/9/2015 18:24:22,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also seen,n/a,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 18:44:30,1633306488,5/9/2015 18:43:57,false,elite,1,30064988,GBR,"","",89.241.94.221,[SYMPTOM],[SYMPTOM],seen in,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 18:52:02,1633309658,5/9/2015 18:51:41,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also seen,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 19:34:49,1633340616,5/9/2015 19:33:43,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],seen in,n/a,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 19:41:45,1633343194,5/9/2015 19:41:01,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PRIMARY HYPERPARATHYROIDISM is also seen patients with MEN2A ( 7.,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 20:36:25,1633361916,5/9/2015 20:35:34,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],seen in approximately 30%,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 21:46:57,1633386989,5/9/2015 21:46:22,false,neodev,1,28448810,USA,VA,Manassas,98.218.212.74,[SYMPTOM],[SYMPTOM],is also seen,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 21:54:15,1633389423,5/9/2015 21:53:49,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also seen,n/a,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 21:55:47,1633389987,5/9/2015 21:55:33,false,neodev,1,32103286,USA,CA,San Jose,23.27.44.247,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 22:07:11,1633394418,5/9/2015 22:06:30,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PRIMARY HYPERPARATHYROIDISM is seen in patients with MEN2A,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 22:50:27,1633411459,5/9/2015 22:49:11,false,bitcoinget,1,31947120,USA,CA,Arcadia,104.33.83.169,[OTHER],[OTHER],seen,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 22:50:47,1633411595,5/9/2015 22:50:09,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is also seen in,N/A,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911530,5/9/2015 23:25:19,1633426716,5/9/2015 23:24:43,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",seen,n/a,0,79,1,26,84,TWrex-cause,814803-FS1,PRIMARY HYPERPARATHYROIDISM is also seen in approximately 30% of patients with MEN2A ( 7.,PRIMARY HYPERPARATHYROIDISM,MEN2A
717911531,5/9/2015 18:28:22,1633300360,5/9/2015 18:28:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for treatment,n/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 18:52:31,1633309853,5/9/2015 18:51:52,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],treatment,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 18:57:07,1633311383,5/9/2015 18:56:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 19:41:53,1633343261,5/9/2015 19:41:30,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 20:52:17,1633367418,5/9/2015 20:50:36,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER] [TREATS],"[TREATS]
[OTHER]",treatment,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 21:56:12,1633390141,5/9/2015 21:55:52,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],treatment,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 21:58:12,1633390908,5/9/2015 21:57:36,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],versus,n/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 22:01:10,1633392090,5/9/2015 22:00:53,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 22:19:55,1633399125,5/9/2015 22:19:22,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],RIFAMPICIN for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 23:00:33,1633415886,5/9/2015 22:59:45,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 23:24:12,1633426100,5/9/2015 23:23:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for treatment of,N/A,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 23:40:38,1633433501,5/9/2015 23:39:48,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/9/2015 23:47:15,1633436399,5/9/2015 23:46:52,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],RIFAMPICIN treatment DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,N/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/10/2015 00:05:05,1633445062,5/10/2015 00:03:38,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[NONE],[NONE],N/A,a randomized trial doesn't seem to fit any of the other categories,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911531,5/10/2015 00:30:00,1633455275,5/10/2015 00:28:33,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,145,90,-1,183,100,TWrex-cause,800095-FS1,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN
717911532,5/9/2015 13:52:44,1633187365,5/9/2015 13:52:10,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],administration,n/a,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:17:38,1633198160,5/9/2015 14:17:15,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],administration,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:17:49,1633198260,5/9/2015 14:16:45,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],administration of,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:48:32,1633211635,5/9/2015 14:47:46,false,clixsense,1,16498372,CAN,ON,Toronto,76.10.131.218,[TREATS],[TREATS],administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:52:16,1633213133,5/9/2015 14:52:01,false,neodev,1,31789301,USA,VA,Mclean,63.141.204.56,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",N/A,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:52:30,1633213274,5/9/2015 14:51:57,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],in patients with,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 14:53:17,1633213549,5/9/2015 14:52:47,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],clinical trial in patients,n/a,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:04:48,1633218727,5/9/2015 15:02:51,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"randomized clinical trial comparing breakfast, dinner, bedtime administration",N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:11:06,1633221399,5/9/2015 15:10:27,false,instagc,1,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:30:08,1633229583,5/9/2015 15:29:41,false,prodege,1,22031444,GBR,"","",80.44.147.241,[TREATS],[TREATS],administration of,N/a,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:31:26,1633230189,5/9/2015 15:31:08,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],administration of,n/a,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:32:00,1633230493,5/9/2015 15:31:32,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],clinical trial administration of INSULIN,n/a,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:37:44,1633232990,5/9/2015 15:36:57,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES,N/A,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:49:14,1633238535,5/9/2015 15:47:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,Insulin glargine helps to treat diabetes,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911532,5/9/2015 15:49:53,1633238816,5/9/2015 15:48:14,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],administration of,treated at different times of day,157,123,-1,171,139,TWrex-cause,803880-FS1,"Hamann A, Matthaei S, Rosak C et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of INSULIN GLARGINE in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
717911533,5/10/2015 00:23:38,1633453134,5/10/2015 00:23:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],DOXYCYCLINE treatment EARLY SYPHILIS,n/a,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 00:27:43,1633454350,5/10/2015 00:26:23,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",compared with for the treatment of,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 01:20:23,1633472016,5/10/2015 01:19:10,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],DOXYCYCLINE compared with for the treatment EARLY SYPHILIS,n/a,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 01:42:03,1633478934,5/10/2015 01:41:25,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],DOXYCYCLINE EARLY SYPHILIS,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 01:48:39,1633481333,5/10/2015 01:47:22,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],the treatment of,n/a,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 01:54:09,1633483322,5/10/2015 01:53:51,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],DOXYCYCLINE for the treatment of EARLY SYPHILIS,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 02:14:43,1633490034,5/10/2015 02:13:40,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],DOXYCYCLINE treatment EARLY SYPHILIS,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 02:20:37,1633492091,5/10/2015 02:19:53,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"DOXYCYCLINE for treatment of EARLY S<span id=""transmark""></span>YPHILIS",doxycycline treats syphilis,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 02:49:02,1633501475,5/10/2015 02:48:39,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],DOXYCYCLINE EARLY SYPHILIS,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 02:55:35,1633503339,5/10/2015 02:55:04,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",DOXYCYCLINE EARLY SYPHILIS,y/a,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 03:49:08,1633517374,5/10/2015 03:47:44,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[OTHER],[OTHER],DOXYCYCLINE for the treatment of EARLY SYPHILIS,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 04:46:13,1633529808,5/10/2015 04:44:41,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[OTHER],[OTHER],DOXYCYCLINE EARLY SYPHILIS,early syphylis is treated with doxycyline,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 06:46:58,1633555564,5/10/2015 06:44:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 07:23:57,1633562621,5/10/2015 07:22:21,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treatment,Treatment of,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911533,5/10/2015 07:28:47,1633563799,5/10/2015 07:26:33,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,69,0,-1,82,11,TWrex-cause,803882-FS1,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE
717911534,5/10/2015 00:34:35,1633456914,5/10/2015 00:33:01,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[NONE],[NONE],N/A,controlled trial didn't seem to fit any of the above categories,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 01:29:03,1633474869,5/10/2015 01:27:48,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[NONE],[NONE],n/a,"possibly a treatment, but for the present just in trial",71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 01:44:14,1633479676,5/10/2015 01:43:47,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER:,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 01:55:22,1633483712,5/10/2015 01:54:13,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],controlled trial,n/a,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 01:56:06,1633484016,5/10/2015 01:55:41,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER: theory.,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 02:19:53,1633491818,5/10/2015 02:18:29,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",controlled trial FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER: serotonergic theory.,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 02:26:33,1633494248,5/10/2015 02:24:51,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"FLUVOXAMINE in OBSESSIVE COMPULSIVE DIS<span id=""transmark""></span>ORDER:",fluvoxamine has been tried in treatment of obsessive compulsive disorder which was utterly stupid,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 02:50:34,1633501971,5/10/2015 02:50:14,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER:,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 02:59:07,1633504538,5/10/2015 02:58:17,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER:,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 03:53:43,1633518446,5/10/2015 03:52:36,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[OTHER],[OTHER],trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER:,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 04:51:14,1633530906,5/10/2015 04:50:34,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[TREATS],[TREATS],FLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER:,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 06:54:15,1633556896,5/10/2015 06:51:49,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],controlled trial,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 07:28:50,1633563807,5/10/2015 07:28:08,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],trial,Trial,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 07:31:35,1633564294,5/10/2015 07:31:04,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[TREATS],[TREATS],trial,n/a,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911534,5/10/2015 07:34:56,1633565039,5/10/2015 07:32:57,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[TREATS],[TREATS],controlled trial,N/A,71,56,-1,99,67,TWrex-cause,803367-FS1,"Jenike JA, Hyman S, Baer L et al. A controlled trial of FLUVOXAMINE in OBSESSIVE COMPULSIVE DISORDER: implications for a serotonergic theory.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
717911535,5/9/2015 23:12:44,1633421023,5/9/2015 23:10:29,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Cyclocryotherapy can be performed for glaucomatous painful blind eye and glaucoma,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 00:20:43,1633452024,5/10/2015 00:19:50,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],commercialized a new implant,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 00:21:13,1633452203,5/10/2015 00:20:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GLAUCOMATOUS PAINFUL BLIND EYE and GLAUCOMA Cyclocryotherapy,n/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 00:43:54,1633459652,5/10/2015 00:43:13,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[OTHER],[OTHER],for some cases of,N/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 01:06:57,1633467291,5/10/2015 01:06:03,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],And for GLAUCOMATOUS PAINFUL BLIND EYE and some GLAUCOMA,n/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 01:09:59,1633468405,5/10/2015 01:08:32,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [ASSOCIATED_WITH] [SIDE_EFFECT] [PREVENTS],"[PREVENTS]
[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",GLAUCOMATOUS PAINFUL BLIND EYE GLAUCOMA,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 01:27:40,1633474394,5/10/2015 01:26:16,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28],n/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 01:38:01,1633477674,5/10/2015 01:37:33,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",GLAUCOMATOUS PAINFUL BLIND EYE GLAUCOMA Cyclocryotherapy,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 01:43:11,1633479324,5/10/2015 01:42:38,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",GLAUCOMATOUS PAINFUL BLIND EYE GLAUCOMA,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 02:12:02,1633489051,5/10/2015 02:10:37,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[SYMPTOM],[SYMPTOM],"GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GL<span id=""transmark""></span>AUCOMA",haven't,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 02:45:24,1633500386,5/10/2015 02:44:58,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GLAUCOMATOUS PAINFUL BLIND GLAUCOMA,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 02:51:36,1633502328,5/10/2015 02:50:51,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[PREVENTS],[PREVENTS],GLAUCOMATOUS PAINFUL BLIND EYE TR ClarifEYE.,y/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 03:05:13,1633506228,5/10/2015 03:04:39,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],cases of,n/a,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 03:43:05,1633515806,5/10/2015 03:42:16,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],GLAUCOMATOUS PAINFUL BLIND EYE GLAUCOMA,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911535,5/10/2015 04:39:43,1633528273,5/10/2015 04:36:57,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[IS_A],[IS_A],GLAUCOMATOUS PAINFUL BLIND EYE GLAUCOMA,N/A,8,8,-1,37,16,TWrex-cause,802831-FS1,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA
717911536,5/9/2015 16:30:42,1633255199,5/9/2015 16:29:12,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],occur,none,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 17:12:35,1633271738,5/9/2015 17:12:00,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],functional abnormalities,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 17:13:12,1633271949,5/9/2015 17:12:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],THROMBOCYTOPENIC DISORDER and in Chediak Higashi syndrome,n/a,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 18:21:38,1633297922,5/9/2015 18:20:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in the,n/a,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 18:37:54,1633303625,5/9/2015 18:37:04,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[OTHER],[OTHER],and,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 18:48:46,1633308476,5/9/2015 18:48:15,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[LOCATION],[LOCATION],occur in,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 19:29:37,1633338437,5/9/2015 19:28:31,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 19:33:28,1633340001,5/9/2015 19:32:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],THROMBOCYTOPENIC DISORDER Chediak Higashi syndrome CHEDIAK HIGASHI SYNDROME.,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 20:27:36,1633358767,5/9/2015 20:26:46,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 21:38:06,1633384168,5/9/2015 21:35:48,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[NONE],[NONE],N/A,I believe that there's no relation between those terms.,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 21:50:31,1633388079,5/9/2015 21:49:58,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],and,n/a,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 21:52:12,1633388644,5/9/2015 21:51:51,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS] [NONE],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",no,no,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 21:59:16,1633391409,5/9/2015 21:57:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated THROMBOCYTOPENIC DISORDER CHEDIAK HIGASHI SYNDROME.,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 22:28:06,1633402184,5/9/2015 22:26:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911536,5/9/2015 22:42:53,1633408350,5/9/2015 22:41:44,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],functional abnormalities,n/a,98,186,1,122,210,TWrex-cause,813845-FS1,"Large platelets associated with functional abnormalities also occur in the May Hegglin anomaly, a THROMBOCYTOPENIC DISORDER with abnormal WBCs, and in the Chediak Higashi syndrome (see  CHEDIAK HIGASHI SYNDROME.",THROMBOCYTOPENIC DISORDER,CHEDIAK HIGASHI SYNDROME
717911537,5/9/2015 13:44:42,1633184211,5/9/2015 13:43:29,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused by,n/a,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 13:45:15,1633184446,5/9/2015 13:44:22,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 13:50:56,1633186719,5/9/2015 13:50:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:11:31,1633195658,5/9/2015 14:11:03,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:25:05,1633201566,5/9/2015 14:24:09,false,clixsense,1,32254355,CAN,ON,London,70.53.114.210,[MANIFESTATION],[MANIFESTATION],caused by,Bacteria is the cause of infective endocarditis.,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:38:58,1633207590,5/9/2015 14:37:06,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[SYMPTOM],[SYMPTOM],INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:39:26,1633207751,5/9/2015 14:38:40,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],is caused by,I didn't select none,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:47:33,1633211208,5/9/2015 14:46:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:48:48,1633211743,5/9/2015 14:47:54,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused by,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:49:48,1633212192,5/9/2015 14:49:09,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",N/A,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:51:22,1633212800,5/9/2015 14:49:54,false,instagc,1.0,19740138,CAN,"","",50.69.96.237,[CAUSES],[CAUSES],caused by,n/a,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:51:29,1633212845,5/9/2015 14:49:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],INFECTIVE ENDOCARDITIS BACTERIA,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 14:59:29,1633216303,5/9/2015 14:58:17,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CAUSES],[CAUSES],INFECTIVE ENDOCARDITIS caused by BACTERIA,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 15:24:38,1633227009,5/9/2015 15:24:24,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,N/A,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911537,5/9/2015 15:26:26,1633227948,5/9/2015 15:25:57,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,206,308,1,227,316,TWrex-cause,810737-FS1,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
717911538,5/9/2015 13:56:41,1633189230,5/9/2015 13:56:32,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 14:20:40,1633199506,5/9/2015 14:20:07,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 14:25:26,1633201755,5/9/2015 14:25:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 14:54:00,1633213853,5/9/2015 14:53:41,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[CONTRAINDICATES] [NONE],"[CONTRAINDICATES]
[NONE]",N/A,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 14:54:42,1633214143,5/9/2015 14:54:29,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment of,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 14:57:52,1633215478,5/9/2015 14:57:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:13:06,1633222198,5/9/2015 15:12:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:18:37,1633224497,5/9/2015 15:16:08,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],treatment,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:35:59,1633232185,5/9/2015 15:35:47,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment,n/a,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:38:07,1633233188,5/9/2015 15:37:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:41:04,1633234626,5/9/2015 15:40:32,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:58:44,1633242646,5/9/2015 15:58:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,used for treatment,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 15:58:52,1633242721,5/9/2015 15:57:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,CHRONIC POSTHERPETIC NEURALGIA  has no stated relationship to TOPICAL CAPSAICIN,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 16:18:02,1633250415,5/9/2015 16:17:38,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],treatment of,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911538,5/9/2015 16:38:57,1633258510,5/9/2015 16:38:32,false,instagc,1.0,22981457,CAN,ON,Kitchener,174.113.174.129,[TREATS],[TREATS],treatment of,N/A,31,0,-1,60,17,TWrex-cause,804340-FS1,TOPICAL CAPSAICIN treatment of CHRONIC POSTHERPETIC NEURALGIA,CHRONIC POSTHERPETIC NEURALGIA,TOPICAL CAPSAICIN
717911539,5/9/2015 17:19:45,1633274770,5/9/2015 17:18:27,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],"conjunctivitis, otitis media, epiglottitis,",N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 17:20:00,1633274887,5/9/2015 17:19:26,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MENINGOCOCCAL INFECTIONS associated with N MENINGITIDIS,n/a,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 18:24:21,1633298910,5/9/2015 18:24:01,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 18:43:55,1633306169,5/9/2015 18:42:39,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[IS_A],[IS_A],MENINGOCOCCAL INFECTIONS,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 18:51:40,1633309549,5/9/2015 18:51:10,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 19:33:43,1633340055,5/9/2015 19:33:04,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 19:41:00,1633342998,5/9/2015 19:39:56,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MENINGOCOCCAL INFECTIONS unusual syndromes associated with N MENINGITIDIS,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 20:35:34,1633361564,5/9/2015 20:34:57,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 21:46:21,1633386822,5/9/2015 21:45:28,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[MANIFESTATION],[MANIFESTATION],syndromes,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 21:53:48,1633389156,5/9/2015 21:53:31,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 21:55:30,1633389871,5/9/2015 21:55:10,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[PREVENTS] [CAUSES] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 22:06:29,1633394099,5/9/2015 22:05:50,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MENINGOCOCCAL INFECTIONS associated with N MENINGITIDIS,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 22:49:10,1633410996,5/9/2015 22:48:26,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 22:50:07,1633411331,5/9/2015 22:49:26,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911539,5/9/2015 23:24:43,1633426404,5/9/2015 23:23:41,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,16,83,1,39,97,TWrex-cause,812085-FS1,"3,    25  Other MENINGOCOCCAL INFECTIONS  Other unusual syndromes associated with  N MENINGITIDIS  include conjunctivitis, otitis media, epiglottitis, arthritis, and pericarditis.",MENINGOCOCCAL INFECTIONS,N MENINGITIDIS
717911540,5/9/2015 14:25:05,1633201574,5/9/2015 14:24:31,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosing if patient has,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 14:43:35,1633209429,5/9/2015 14:42:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",if a patient has,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 14:58:14,1633215668,5/9/2015 14:57:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],has,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:06:01,1633219228,5/9/2015 15:05:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],if a patient has,n/a,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:22:05,1633225990,5/9/2015 15:21:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosing FMS,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:25:54,1633227667,5/9/2015 15:25:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SYMPTOM],[SYMPTOM],diagnosing FMS if patient has WIDESPREAD PAIN,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:41:23,1633234776,5/9/2015 15:40:59,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],diagnosing,n/a,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:46:21,1633237173,5/9/2015 15:45:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],diagnosing if a patient has,n/a,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 15:46:28,1633237243,5/9/2015 15:45:36,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],diagnosing FMS if a patient has WIDESPREAD PAIN,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 16:09:51,1633247196,5/9/2015 16:08:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],diagnosing,a symptom of,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 16:14:28,1633249029,5/9/2015 16:13:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],has,none,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 16:59:33,1633266752,5/9/2015 16:58:43,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],FMS ACR,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 17:04:09,1633268803,5/9/2015 17:03:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],diagnosing FMS has WIDESPREAD PAIN,n/a,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 18:02:43,1633290996,5/9/2015 18:01:38,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosing FMS ACR criteria patient has WIDESPREAD PAIN,N/A,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911540,5/9/2015 18:03:52,1633291390,5/9/2015 18:03:00,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosing,Diagnosis,85,48,1,99,51,TWrex-cause,814385-FS1,"• Count the number of tender points, diagnosing FMS by ACR criteria if a patient has WIDESPREAD PAIN  plus  at least 11 tender points.",WIDESPREAD PAIN,FMS
717911541,5/9/2015 18:53:12,1633310099,5/9/2015 18:52:33,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[PART_OF],[PART_OF],include,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 18:57:35,1633311555,5/9/2015 18:57:08,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],include,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 19:42:23,1633343389,5/9/2015 19:41:54,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],include,n/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 20:54:48,1633368332,5/9/2015 20:52:18,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PART_OF],[PART_OF],include,n/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 21:56:49,1633390415,5/9/2015 21:56:14,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[MANIFESTATION],[MANIFESTATION],include,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 21:58:34,1633391094,5/9/2015 21:58:12,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PART_OF],[PART_OF],include,n/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 22:01:27,1633392158,5/9/2015 22:01:11,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 22:21:03,1633399628,5/9/2015 22:19:57,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],NARROW QRS COMPLEX TACHYARRHYTHMIAS include MULTIFOCAL ATRIAL TACHYCARDIA,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 23:01:12,1633416210,5/9/2015 23:00:33,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",include,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 23:25:11,1633426614,5/9/2015 23:24:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",include with and,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 23:42:12,1633434187,5/9/2015 23:40:38,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,n/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/9/2015 23:48:19,1633436917,5/9/2015 23:47:16,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],NARROW QRS COMPLEX TACHYARRHYTHMIAS MULTIFOCAL ATRIAL TACHYCARDIA,N/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/10/2015 00:06:30,1633445768,5/10/2015 00:05:10,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[OTHER],[OTHER],"variable AV conduction,",N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/10/2015 00:31:27,1633455795,5/10/2015 00:30:01,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",include,N/a,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911541,5/10/2015 00:41:40,1633459006,5/10/2015 00:41:01,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PART_OF],[PART_OF],include,N/A,156,11,1,184,46,TWrex-cause,813298-FS1,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS
717911542,5/9/2015 18:59:06,1633312038,5/9/2015 18:58:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 19:44:50,1633344244,5/9/2015 19:44:20,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],Treatment,n/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 20:59:59,1633370001,5/9/2015 20:58:23,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS] [OTHER],"[PREVENTS]
[OTHER]",Treatment,n/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 21:58:34,1633391088,5/9/2015 21:58:08,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[MANIFESTATION] [SIDE_EFFECT],"[MANIFESTATION]
[SIDE_EFFECT]",increasing,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 21:59:51,1633391601,5/9/2015 21:59:30,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],doses,n/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 22:02:33,1633392652,5/9/2015 22:02:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 22:25:10,1633401189,5/9/2015 22:24:46,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],Treatment of,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 23:04:53,1633417685,5/9/2015 23:04:21,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],Treatment,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 23:28:03,1633427866,5/9/2015 23:27:22,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 23:46:32,1633436127,5/9/2015 23:45:37,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],doses,n/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/9/2015 23:50:22,1633437941,5/9/2015 23:49:35,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatment of HAIRY CELL LEUKEMIA RECOMBINANT ALPHA A INTERFERON,N/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/10/2015 00:11:52,1633448104,5/10/2015 00:11:11,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],Treatment of,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/10/2015 00:36:13,1633457407,5/10/2015 00:34:55,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],Treatment,N/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/10/2015 00:47:09,1633460587,5/10/2015 00:46:16,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],Treatment,n/a,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911542,5/10/2015 00:57:30,1633464235,5/10/2015 00:54:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Treatment HAIRY CELL LEUKEMIA RECOMBINANT ALPHA A INTERFERON,N/A,55,100,-1,73,130,TWrex-cause,803775-FS1,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON
717911543,5/9/2015 17:23:31,1633276217,5/9/2015 17:22:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],For treatment of PERTUSSIS ERYTHROMYCIN,n/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 18:25:32,1633299372,5/9/2015 18:25:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],drug of choice;,n/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 18:46:15,1633307447,5/9/2015 18:45:51,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],treatment,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 18:53:37,1633310179,5/9/2015 18:52:45,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 19:36:59,1633341561,5/9/2015 19:36:28,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 19:43:50,1633343939,5/9/2015 19:43:09,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PERTUSSIS CDC and AAP recommend ERYTHROMYCIN drug of choice;,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 20:41:48,1633363812,5/9/2015 20:39:30,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER] [TREATS],"[TREATS]
[OTHER]",treatment recommend,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 21:50:46,1633388165,5/9/2015 21:49:56,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",treatment alternative,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 21:55:20,1633389817,5/9/2015 21:55:04,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],or,n/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 21:56:53,1633390438,5/9/2015 21:56:26,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 22:09:56,1633395471,5/9/2015 22:08:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",For treatment and postexposure prophylaxis of PERTUSSIS ERYTHROMYCIN,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 22:53:51,1633412962,5/9/2015 22:53:03,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],drug of choice;,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 23:16:14,1633422576,5/9/2015 23:14:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment,N/A,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 23:29:36,1633428539,5/9/2015 23:27:51,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,n/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911543,5/9/2015 23:40:45,1633433519,5/9/2015 23:39:59,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],treatment recommend ERYTHROMYCIN,N/a,75,180,-1,83,192,TWrex-cause,804743-FS1,"203 ,   324 ,   333 ,   334  For treatment and postexposure prophylaxis of PERTUSSIS in adults and children ≥1 month of age, CDC and AAP recommend azithromycin, clarithromycin, or ERYTHROMYCIN as drug of choice;  203 ,   334   co trimoxazole is an alternative for those ≥2 months of age when a macrolide cannot be used.",PERTUSSIS,ERYTHROMYCIN
717911544,5/9/2015 23:09:48,1633419887,5/9/2015 23:07:07,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[NONE] [OTHER],"[OTHER]
[NONE]",N/A,reducing sensory input cause neuropathic pain. augmenting sensory input lessons neuralgia. sensory input is what connects neuropathic pain and neuralgia.,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/9/2015 23:51:18,1633438308,5/9/2015 23:50:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],lessens,n/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/9/2015 23:53:26,1633439345,5/9/2015 23:52:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN NEURALGIA,N/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 00:18:31,1633451158,5/10/2015 00:16:47,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",more often cause and augmenting,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 00:42:42,1633459354,5/10/2015 00:40:18,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],lessens,N/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 00:58:09,1633464497,5/10/2015 00:55:18,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],cause lessens,n/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 01:04:34,1633466422,5/10/2015 01:03:27,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and augmenting sensory input often lessens,n/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 01:06:34,1633467174,5/10/2015 01:04:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]",NEUROPATHIC PAIN NEURALGIA,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 01:36:39,1633477262,5/10/2015 01:36:02,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",NEUROPATHIC PAIN NEURALGIA,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 01:41:46,1633478859,5/10/2015 01:41:06,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",Nerve injury cause NEUROPATHIC PAIN NEURALGIA,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 02:08:27,1633487978,5/10/2015 02:05:45,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[IS_A],[IS_A],"augmenting sensory input lessens NEU<span id=""transmark""></span>RALGIA","there is no clear explanation to be marked in given sentence, but neuropathic pain and neuralgia are the same thing and it appears off the sentence when read carefully",56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 02:44:31,1633500056,5/10/2015 02:44:12,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],NEUROPATHIC PAIN NEURALGIA,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 02:49:46,1633501707,5/10/2015 02:48:21,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],NEUROPATHIC PAIN NEURALGIA,y/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 03:03:59,1633505734,5/10/2015 03:03:13,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CONTRAINDICATES],[CONTRAINDICATES],NEUROPATHIC,n/a,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911544,5/10/2015 03:41:33,1633515367,5/10/2015 03:40:38,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[IS_A],[IS_A],Nerve NEUROPATHIC PAIN NEURALGIA,N/A,56,130,1,71,139,TWrex-cause,814666-FS1,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA
717911545,5/10/2015 00:21:53,1633452527,5/10/2015 00:21:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CHLORAMBUCIL primary therapy CHRONIC LYMPHOCYTIC LEUKEMIA,n/a,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 00:23:24,1633453062,5/10/2015 00:21:35,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],as primary therapy,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 00:45:30,1633460108,5/10/2015 00:44:54,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],primary therapy,N/a,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 01:12:12,1633469200,5/10/2015 01:11:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Fludarabine CHLORAMBUCIL primary therapy CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 01:14:03,1633469805,5/10/2015 01:13:34,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA,n/a,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 01:39:02,1633478018,5/10/2015 01:38:37,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],CHLORAMBUCIL CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 01:41:04,1633478647,5/10/2015 01:39:54,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],primary therapy,n/a,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 01:44:58,1633479929,5/10/2015 01:44:09,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 02:13:57,1633489789,5/10/2015 02:12:43,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCY<span id=""transmark""></span>TIC LEUKEMIA",CHLORAMBUCIL is a proposed treatment of CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 02:46:05,1633500571,5/10/2015 02:45:48,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[TREATS],[TREATS],CHLORAMBUCIL CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 02:53:07,1633502775,5/10/2015 02:52:12,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[MANIFESTATION],[MANIFESTATION],CHLORAMBUCIL CHRONIC LYMPHOCYTIC LEUKEMIA,y/a,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 03:44:22,1633516159,5/10/2015 03:43:56,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[NONE],[NONE],N/A,One is a condition the other is a medication,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 04:42:49,1633528950,5/10/2015 04:42:01,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[TREATS],[TREATS],CHLORAMBUCIL CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 06:35:56,1633553546,5/10/2015 06:33:36,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911545,5/10/2015 07:19:04,1633561655,5/10/2015 07:18:18,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy,Therapy,101,65,-1,128,77,TWrex-cause,803415-FS1,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
717911546,5/9/2015 17:16:10,1633273274,5/9/2015 17:15:39,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],SEVERE HYPERTENSION,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 17:16:44,1633273555,5/9/2015 17:15:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INTRAVENOUS NICARDIPINE for treatment SEVERE HYPERTENSION,n./a,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 18:23:05,1633298459,5/9/2015 18:22:47,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 18:40:36,1633304583,5/9/2015 18:40:10,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],treatment of,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 18:50:10,1633309070,5/9/2015 18:49:54,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 19:31:21,1633339082,5/9/2015 19:31:01,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 19:36:27,1633341317,5/9/2015 19:35:56,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],INTRAVENOUS NICARDIPINE treatment of SEVERE HYPERTENSION,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 20:32:14,1633360438,5/9/2015 20:31:30,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],treatment,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 21:43:41,1633385994,5/9/2015 21:43:05,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],treatment,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 21:52:19,1633388690,5/9/2015 21:52:02,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 21:53:38,1633389115,5/9/2015 21:53:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 22:03:06,1633392783,5/9/2015 22:02:35,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],INTRAVENOUS NICARDIPINE treatment of SEVERE HYPERTENSION,n/a,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 22:32:51,1633404273,5/9/2015 22:32:02,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 22:48:25,1633410574,5/9/2015 22:47:58,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911546,5/9/2015 23:22:15,1633425185,5/9/2015 23:21:16,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,82,37,-1,100,60,TWrex-cause,800700-FS1,"Wallin JD, Fletcher E, Ram VS et al. INTRAVENOUS NICARDIPINE for the treatment of SEVERE HYPERTENSION",SEVERE HYPERTENSION,INTRAVENOUS NICARDIPINE
717911547,5/9/2015 18:25:52,1633299478,5/9/2015 18:25:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],first line prevention,n/a,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 18:46:48,1633307654,5/9/2015 18:46:18,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[PREVENTS],[PREVENTS],first line prevention agent,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 18:54:18,1633310388,5/9/2015 18:53:38,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevention,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 19:37:19,1633341693,5/9/2015 19:37:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 19:45:04,1633344312,5/9/2015 19:43:51,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],INH TB problematic poor adherence resistance INH therapy.,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 20:42:33,1633364024,5/9/2015 20:41:50,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],prevention,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 21:51:24,1633388371,5/9/2015 21:50:47,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[PREVENTS],[PREVENTS],prevention,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 21:55:34,1633389886,5/9/2015 21:55:21,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],therapy.,n/a,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 21:57:59,1633390844,5/9/2015 21:56:56,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 22:10:47,1633395730,5/9/2015 22:09:57,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],INH first line prevention agent for TB,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 22:54:10,1633413099,5/9/2015 22:53:52,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PREVENTS],[PREVENTS],prevention,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 23:17:20,1633423072,5/9/2015 23:16:15,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],first line prevention agent,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 23:34:33,1633430865,5/9/2015 23:34:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 23:42:17,1633434225,5/9/2015 23:40:46,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],TB increasing resistance to INH therapy.,N/a,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911547,5/9/2015 23:48:18,1633436915,5/9/2015 23:47:25,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[PREVENTS],[PREVENTS],prevention,N/A,63,0,-1,64,3,TWrex-cause,800306-FS1,"INH currently the first line prevention agent for reactivation TB in persons with HIV infection is problematic because of poor adherence to 12 month therapy, hepatotoxity, and increasing resistance to INH therapy.",TB,INH
717911548,5/9/2015 14:29:07,1633203253,5/9/2015 14:28:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEADACHE MIGRAINE,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 14:54:38,1633214093,5/9/2015 14:53:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],HEADACHE MIGRAINE,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:00:18,1633216739,5/9/2015 15:00:00,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],disorders,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:09:45,1633220890,5/9/2015 15:09:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEADACHE MIGRAINE,n/a,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:30:44,1633229788,5/9/2015 15:29:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis Review:,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:32:57,1633230863,5/9/2015 15:32:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[IS_A],[IS_A],HEADACHE MIGRAINE,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:47:04,1633237578,5/9/2015 15:45:51,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],neurological disorders,n/a,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 15:56:18,1633241498,5/9/2015 15:55:52,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],disorders,n/a,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 16:19:50,1633251003,5/9/2015 16:18:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],HEADACHE MIGRAINE,used together to describe,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 16:25:03,1633252993,5/9/2015 16:23:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,HEADACHE similar to  MIGRAINE,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 17:09:40,1633270883,5/9/2015 17:09:17,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],migraine,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 17:10:59,1633271208,5/9/2015 17:10:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],HEADACHE MIGRAINE disorders,n/a,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 18:09:41,1633293477,5/9/2015 18:08:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],HEADACHE MIGRAINE,N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 18:19:52,1633297200,5/9/2015 18:19:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],disorders,n/a,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911548,5/9/2015 18:32:57,1633301752,5/9/2015 18:32:07,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PREVENTS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Diagnostic techniques,",N/A,305,314,1,312,322,TWrex-cause,814706-FS1,"Diagnosis  Review: History and physical examination can accurately identify migraine and the need for neuroimaging in patients with headache  Emergency Medicine General Internal Medicine/Family Practitioner/General Practitioner Neurology  About Star Ratings  Keywords: Diagnostic techniques, neurological HEADACHE MIGRAINE disorders  ACP Journal Club.",HEADACHE,MIGRAINE
717911549,5/9/2015 13:53:07,1633187565,5/9/2015 13:52:45,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy with,n/a,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 14:18:20,1633198471,5/9/2015 14:17:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",in,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 14:20:16,1633199275,5/9/2015 14:17:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],controlled trial.,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 14:52:29,1633213269,5/9/2015 14:52:17,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[LOCATION] [NONE],"[LOCATION]
[NONE]",N/A,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 14:52:54,1633213407,5/9/2015 14:52:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy with cisapride in,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 14:53:38,1633213665,5/9/2015 14:53:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy,n/a,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:06:31,1633219494,5/9/2015 15:04:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],double blind placebo controlled trial.,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:11:43,1633221672,5/9/2015 15:11:08,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],Combined therapy with CIMETIDINE in SEVERE REFLUX ESOPHAGITIS:,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:30:33,1633229732,5/9/2015 15:30:09,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[TREATS],[TREATS],therapy with,N/a,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:31:53,1633230425,5/9/2015 15:31:26,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],therapy with,n/a,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:32:20,1633230653,5/9/2015 15:32:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy with,n/a,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:38:06,1633233183,5/9/2015 15:37:46,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],Combined therapy with CIMETIDINE in SEVERE REFLUX ESOPHAGITIS:,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:50:01,1633238890,5/9/2015 15:49:19,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[TREATS],[TREATS],therapy with,N/A,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:50:47,1633239186,5/9/2015 15:49:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,CIMETIDINE is used to treat the symptoms of  SEVERE REFLUX ESOPHAGITIS,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911549,5/9/2015 15:51:09,1633239325,5/9/2015 15:49:58,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy with,used to treat with other drug,95,81,-1,119,91,TWrex-cause,800826-FS1,"Galmiche JP, Brandstatter G, Evreux M et al. Combined therapy with cisapride and CIMETIDINE in SEVERE REFLUX ESOPHAGITIS: A double blind placebo controlled trial.",SEVERE REFLUX ESOPHAGITIS,CIMETIDINE
717911550,5/9/2015 14:23:58,1633201003,5/9/2015 14:23:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],caused,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 14:39:52,1633207942,5/9/2015 14:38:01,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 14:57:06,1633215178,5/9/2015 14:56:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused by,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:03:21,1633218009,5/9/2015 15:02:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:19:53,1633225028,5/9/2015 15:18:54,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Nocardiosis Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS caused by NOCARDIA,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:24:00,1633226754,5/9/2015 15:22:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CAUSES],[CAUSES],NOCARDIOSIS caused by NOCARDIA,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:39:55,1633234184,5/9/2015 15:38:47,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,n/a,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:44:08,1633236204,5/9/2015 15:43:19,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 15:44:54,1633236626,5/9/2015 15:44:28,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],NOCARDIOSIS caused by NOCARDIA,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 16:07:25,1633246368,5/9/2015 16:06:02,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,causes it,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 16:09:08,1633246925,5/9/2015 16:06:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,NOCARDIA causes NOCARDIOSIS,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 16:58:09,1633266209,5/9/2015 16:57:54,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Tetracyclines,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 17:02:45,1633268228,5/9/2015 17:01:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NOCARDIOSIS + caused by NOCARDIA,n/a,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 18:00:04,1633290182,5/9/2015 17:58:38,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],caused,Cuse,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911550,5/9/2015 18:00:29,1633290280,5/9/2015 17:59:51,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],NOCARDIOSIS + caused by NOCARDIA,N/A,89,119,1,99,127,TWrex-cause,810907-FS1,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA
717911551,5/9/2015 17:22:46,1633275889,5/9/2015 17:22:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],V CHOLERAE to confirm diagnosis of CHOLERA,n/a,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 17:23:40,1633276256,5/9/2015 17:23:18,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],CHOLERA,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 18:25:13,1633299244,5/9/2015 18:24:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],confirm diagnosis,n/a,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 18:45:50,1633307251,5/9/2015 18:45:02,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[CAUSES],[CAUSES],confirm the diagnosis,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 18:52:44,1633309962,5/9/2015 18:52:28,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 19:36:27,1633341324,5/9/2015 19:35:35,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],confirm the diagnosis,n/a,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 19:43:07,1633343679,5/9/2015 19:42:26,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Obtain stool cultures for V CHOLERAE diagnosis CHOLERA,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 20:39:29,1633363187,5/9/2015 20:37:16,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],confirm the diagnosis,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 21:49:55,1633387896,5/9/2015 21:47:34,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],diagnosis,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 21:55:03,1633389715,5/9/2015 21:54:40,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[MANIFESTATION],[MANIFESTATION],confirm,n/a,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 21:56:24,1633390233,5/9/2015 21:56:11,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 22:08:40,1633395015,5/9/2015 22:07:47,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION],[MANIFESTATION],V CHOLERAE confirm the diagnosis of CHOLERA,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 22:53:02,1633412518,5/9/2015 22:52:18,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[MANIFESTATION] [PART_OF],"[MANIFESTATION]
[PART_OF]",confirm,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 23:14:48,1633421945,5/9/2015 23:14:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],confirm the diagnosis,N/A,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911551,5/9/2015 23:26:59,1633427355,5/9/2015 23:26:31,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,n/a,33,31,1,39,41,TWrex-cause,811161-FS1,3.3 Obtain stool cultures for  V CHOLERAE  O1 or O139 to confirm the diagnosis of CHOLERA,CHOLERA,V CHOLERAE
717911552,5/10/2015 00:24:18,1633453369,5/10/2015 00:24:03,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PCD patients have SITUS INVERSUS,n/a,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 00:30:20,1633455420,5/10/2015 00:28:29,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[CAUSES],[CAUSES],argues that the disease may be more common,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 01:22:56,1633472982,5/10/2015 01:21:32,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PCD index patients who have SITUS INVERSUS may be more common than previously suspected;,n/a,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 01:43:19,1633479357,5/10/2015 01:42:32,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PCD SITUS INVERSUS,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 01:51:34,1633482321,5/10/2015 01:49:41,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],who have,n/a,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 01:55:11,1633483656,5/10/2015 01:54:36,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",PCD patients who have SITUS INVERSUS,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 02:17:04,1633490851,5/10/2015 02:15:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],PCD index patients have SITUS INVERSUS (because of randomization of left right symmetry),N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 02:23:31,1633493121,5/10/2015 02:21:26,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"PCD patients have SITUS INVERS<span id=""transmark""></span>US",Primary Ciliary Dyskinesia might be manifected by Situs Invertus,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 02:49:53,1633501758,5/10/2015 02:49:26,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],PCD SITUS INVERSUS,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 02:56:54,1633503779,5/10/2015 02:56:05,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",PCD SITUS INVERSUS,y/a,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 03:51:53,1633518015,5/10/2015 03:50:23,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],The number of PCD index patients who have SITUS INVERSUS argues that the disease may be more common than previously suspected;,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 04:49:18,1633530455,5/10/2015 04:47:46,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[NONE],[NONE],situs inversus pcd,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 06:50:22,1633556162,5/10/2015 06:47:32,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who have,N/A,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 07:26:20,1633563254,5/10/2015 07:25:10,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have,Have,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911552,5/10/2015 07:30:25,1633564089,5/10/2015 07:29:35,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have,n/a,42,14,1,55,17,TWrex-cause,814432-FS1,The number of PCD index patients who have SITUS INVERSUS (because of the randomization of left right symmetry) argues that the disease may be more common than previously suspected; this supposition could be verified if a sensitive and easily used screening test were available.,SITUS INVERSUS,PCD
717911553,5/10/2015 01:40:13,1633478377,5/10/2015 01:39:08,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Common Adverse Effects IBS patients: MIGRAINE dizziness, NAUSEA flatulence,",n/a,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 01:45:55,1633480368,5/10/2015 01:45:35,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 01:58:25,1633484709,5/10/2015 01:57:52,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",Adverse Effects MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 02:02:50,1633486230,5/10/2015 02:01:41,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Common Adverse Effects,n/a,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 02:26:44,1633494337,5/10/2015 02:25:54,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],"MIGRAINE diarrhea,",N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 02:31:57,1633495969,5/10/2015 02:30:47,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"Adverse Effects MIGRAINE NAUS<span id=""transmark""></span>EA",both are symptoms,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 02:51:59,1633502442,5/10/2015 02:51:42,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 03:01:34,1633505145,5/10/2015 03:01:06,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SIDE_EFFECT],[SIDE_EFFECT],MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 03:57:10,1633519320,5/10/2015 03:56:32,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Common Adverse Effects IBS patients: MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 04:53:22,1633531429,5/10/2015 04:52:54,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[SYMPTOM],[SYMPTOM],MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 07:03:42,1633558480,5/10/2015 07:02:37,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],9 Common Adverse Effects,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 07:32:53,1633564590,5/10/2015 07:32:02,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],Effects,Symptoms,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 07:34:29,1633564925,5/10/2015 07:33:53,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",none,none fit,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 07:39:06,1633565686,5/10/2015 07:38:29,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Common Adverse Effects,n/a,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911553,5/10/2015 08:35:53,1633576905,5/10/2015 08:34:30,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],IBS MIGRAINE NAUSEA,N/A,103,57,1,108,65,TWrex-cause,813862-FS1,"1 ,   9  Common Adverse Effects  IBS patients: headache, MIGRAINE dizziness, abdominal pain, diarrhea, NAUSEA flatulence, back pain, leg pain, accidental trauma, arthropathy.",NAUSEA,MIGRAINE
717911554,5/9/2015 13:49:17,1633186005,5/9/2015 13:47:35,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],Treatment,n/a,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:12:17,1633195917,5/9/2015 14:11:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:14:11,1633196685,5/9/2015 14:13:24,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Uses Treatment,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:42:32,1633209050,5/9/2015 14:41:06,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[TREATS],[TREATS],PENTAMIDINE DIISETHIONATE Uses Pneumocystis (PNEUMOCYSTIS CARINII PNEUMONIA Treatment of Pneumocystis jiroveci,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:50:01,1633212268,5/9/2015 14:49:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Uses Treatment,n/a,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:50:05,1633212297,5/9/2015 14:49:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:50:54,1633212610,5/9/2015 14:50:40,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[LOCATION] [NONE],"[LOCATION]
[NONE]",N/A,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 14:57:23,1633215305,5/9/2015 14:56:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],Synonyms: PENTAMIDINE DIISETHIONATE Uses,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:03:47,1633218250,5/9/2015 15:02:28,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],PENTAMIDINE DIISETHIONATE Uses JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:26:16,1633227897,5/9/2015 15:24:55,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[TREATS],[TREATS],Treatment of,N/a,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:27:22,1633228382,5/9/2015 15:26:08,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Uses,n/a,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:29:46,1633229502,5/9/2015 15:29:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],Treatment of,n/a,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:33:23,1633231045,5/9/2015 15:32:39,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,I couldn't understand the relationship,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:39:39,1633234049,5/9/2015 15:37:29,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Treatment of,used in the treatment,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911554,5/9/2015 15:41:51,1633234971,5/9/2015 15:39:37,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[TREATS],[TREATS],Treatment,N/A,137,91,-1,176,116,TWrex-cause,800553-FS1,"1 ,   2 ,   3 ,   4  Class:  Antiprotozoals, Miscellaneous 8:30.92; AP100 (VA)  Synonyms:  PENTAMIDINE DIISETHIONATE  Uses  Pneumocystis JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA  Treatment of  Pneumocystis jiroveci  (formerly  Pneumocystis carinii ) pneumonia (PCP); designated an orphan drug by FDA for this use.",JIROVECI (PNEUMOCYSTIS CARINII PNEUMONIA,PENTAMIDINE DIISETHIONATE
717911555,5/9/2015 19:45:54,1633344604,5/9/2015 19:45:25,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],is,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 21:02:59,1633371113,5/9/2015 21:01:39,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],recurrent attacks,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 21:59:32,1633391491,5/9/2015 21:59:12,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[SIDE_EFFECT],[SIDE_EFFECT],attacks,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 22:00:26,1633391800,5/9/2015 22:00:09,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],attacks,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 22:03:11,1633392824,5/9/2015 22:02:55,false,neodev,1,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 22:26:36,1633401693,5/9/2015 22:25:57,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],is,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 23:06:05,1633418215,5/9/2015 23:05:23,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PART_OF],[PART_OF],is recurrent attacks,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 23:29:06,1633428360,5/9/2015 23:28:31,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],is recurrent attacks of,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 23:48:18,1633436913,5/9/2015 23:47:39,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],attacks,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/9/2015 23:51:23,1633438358,5/9/2015 23:50:53,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],GLOSSOPHARYNGEAL NEURALGIA GLOSSOPHARYNGEAL NEURALGIA is SEVERE PAIN,N/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/10/2015 00:14:30,1633449224,5/10/2015 00:13:33,false,points4rewards,1,28703583,USA,"","",97.73.94.14,[SYMPTOM],[SYMPTOM],recurrent attacks,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/10/2015 00:38:04,1633457944,5/10/2015 00:36:57,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[MANIFESTATION] [IS_A],"[MANIFESTATION]
[IS_A]",is recurrent attacks,N/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/10/2015 00:52:58,1633462668,5/10/2015 00:51:29,false,clixsense,1,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],recurrent attacks,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/10/2015 00:57:28,1633464193,5/10/2015 00:56:29,false,clixsense,1,19294877,USA,MA,Brookline,71.174.185.107,[IS_A],[IS_A],is recurrent attacks of SEVERE PAIN in 9th cranial nerve,n/a,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911555,5/10/2015 01:00:21,1633465080,5/10/2015 00:58:33,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",GLOSSOPHARYNGEAL NEURALGIA GLOSSOPHARYNGEAL NEURALGIA recurrent attacks SEVERE PAIN,N/A,79,0,1,89,26,TWrex-cause,812895-FS1,"GLOSSOPHARYNGEAL NEURALGIA  GLOSSOPHARYNGEAL NEURALGIA is recurrent attacks of SEVERE PAIN in the 9th cranial nerve distribution (posterior pharynx, tonsils, back of the tongue, middle ear.",SEVERE PAIN,GLOSSOPHARYNGEAL NEURALGIA
717911556,5/9/2015 18:27:49,1633300182,5/9/2015 18:27:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],was reduced,n/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 18:51:18,1633309482,5/9/2015 18:50:15,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],patients with,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 18:56:34,1633311202,5/9/2015 18:56:00,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 19:41:11,1633343063,5/9/2015 19:40:17,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],reduced,n/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 20:50:02,1633366691,5/9/2015 20:48:01,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],reduced,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 21:55:22,1633389821,5/9/2015 21:54:41,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],reduced acting,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 21:57:07,1633390505,5/9/2015 21:56:50,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],in patients,n/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 22:00:34,1633391855,5/9/2015 22:00:15,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 22:18:56,1633398834,5/9/2015 22:17:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],was reduced HUMAN INSULIN in patients with TYPE 1 DIABETES;,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 22:58:58,1633415146,5/9/2015 22:57:52,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",in patients with,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 23:22:31,1633425302,5/9/2015 23:19:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],was reduced more with short acting,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 23:38:54,1633432850,5/9/2015 23:38:04,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],patients,n/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 23:46:18,1633436015,5/9/2015 23:45:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],HUMAN INSULIN patients with TYPE 1 DIABETES;,N/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/9/2015 23:58:10,1633441812,5/9/2015 23:55:39,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[PART_OF],[PART_OF],was reduced more with short acting insulin,N/A,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911556,5/10/2015 00:32:16,1633456185,5/10/2015 00:31:28,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced,N/a,132,101,-1,146,114,TWrex-cause,800279-FS1,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN
717911557,5/9/2015 23:07:06,1633418737,5/9/2015 23:06:31,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",caused by,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/9/2015 23:30:52,1633429057,5/9/2015 23:29:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],+,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/9/2015 23:50:32,1633438039,5/9/2015 23:48:46,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/9/2015 23:52:43,1633438995,5/9/2015 23:51:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],PANDEMIC INFLUENZA INFLUENZA VIRUS,N/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 00:16:42,1633450217,5/10/2015 00:15:45,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Treatment or prevention,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 00:40:17,1633458552,5/10/2015 00:39:57,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[CAUSES],[CAUSES],caused,N/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 00:55:17,1633463568,5/10/2015 00:54:06,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],caused by susceptible strains,n/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 01:03:26,1633466075,5/10/2015 01:02:45,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[OTHER],[OTHER],+ caused by susceptible strains of,n/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 01:04:10,1633466287,5/10/2015 01:01:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",Pandemic Influenza PANDEMIC INFLUENZA susceptible strains INFLUENZA VIRUS,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 01:36:00,1633477065,5/10/2015 01:35:20,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES],[CAUSES],PANDEMIC INFLUENZA INFLUENZA,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 01:41:05,1633478649,5/10/2015 01:40:22,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION] [ASSOCIATED_WITH] [IS_A] [PART_OF],"[MANIFESTATION]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",Pandemic Influenza Treatment prevention of PANDEMIC INFLUENZA INFLUENZA VIRUS,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 02:05:44,1633487059,5/10/2015 02:03:56,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"caused by susceptible strains of INFLUENZA VIR<span id=""transmark""></span>US",haven't selected [none],51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 02:44:10,1633499937,5/10/2015 02:43:51,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[CAUSES],[CAUSES],PANDEMIC INFLUENZA INFLUENZA VIRUS,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 02:48:19,1633501273,5/10/2015 02:47:44,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[TREATS],[TREATS],PANDEMIC INFLUENZA INFLUENZA VIRUS,y/a,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911557,5/10/2015 03:40:37,1633515108,5/10/2015 03:38:52,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],caused,N/A,51,110,1,68,125,TWrex-cause,811845-FS1,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS
717911558,5/9/2015 18:55:15,1633310815,5/9/2015 18:53:54,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SIDE_EFFECT],[SIDE_EFFECT],Adverse Effects,N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 18:58:33,1633311906,5/9/2015 18:57:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],Effects,N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 19:44:04,1633344006,5/9/2015 19:43:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Adverse Effects,n/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 20:57:47,1633369268,5/9/2015 20:55:43,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[OTHER],[OTHER],infections,n/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 21:57:49,1633390796,5/9/2015 21:57:07,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS] [MANIFESTATION],"[TREATS]
[MANIFESTATION]","treated test results,",N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 21:59:13,1633391382,5/9/2015 21:58:57,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],"hypotension,",n/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 22:02:01,1633392406,5/9/2015 22:01:46,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 22:23:33,1633400528,5/9/2015 22:21:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"infections URINARY TRACT hypotension, RENAL FAILURE",N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 23:03:54,1633417354,5/9/2015 23:01:33,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[NONE],[NONE],N/A,urinary tract hypotension and renal failure anemia are listed as a common adverse effects,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 23:26:41,1633427284,5/9/2015 23:26:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GI effects,N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 23:45:06,1633435497,5/9/2015 23:43:38,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],Effects,n/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/9/2015 23:49:13,1633437351,5/9/2015 23:48:50,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],URINARY TRACT RENAL FAILURE,N/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/10/2015 00:09:29,1633447039,5/10/2015 00:07:59,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[SYMPTOM],[SYMPTOM],Common Adverse Effects,N/A,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/10/2015 00:34:26,1633456838,5/10/2015 00:33:29,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Common Adverse Effects infections,N/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911558,5/10/2015 00:45:29,1633460121,5/10/2015 00:43:10,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],infections,n/a,319,346,-1,331,359,TWrex-cause,802739-FS1,"Common Adverse Effects  Patients treated for complicated skin and skin structure infections: GI effects (constipation, nausea, diarrhea, vomiting), injection site reactions, nervous system effects (headache, insomnia, dizziness), rash, pruritus, abnormal liver function test results, CK elevations, infections (fungal, URINARY TRACT hypotension, RENAL FAILURE anemia, dyspnea, fever.",URINARY TRACT,RENAL FAILURE
717911559,5/10/2015 01:32:11,1633475989,5/10/2015 01:31:09,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"is clinical constellation of hemolysis, elevated liver TEST RESULTS occurs in third trimester.",n/a,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 01:45:06,1633480011,5/10/2015 01:44:43,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],HELLP SYNDROME TEST RESULTS THROMBOCYTOPENIA PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 01:57:23,1633484381,5/10/2015 01:56:45,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",HELLP SYNDROME THROMBOCYTOPENIA (LOW PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 01:58:47,1633484797,5/10/2015 01:56:50,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],clinical constellation of,n/a,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 02:24:04,1633493348,5/10/2015 02:22:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",HELLP SYNDROME clinical constellation (LOW PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 02:29:57,1633495298,5/10/2015 02:27:15,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[NONE],[NONE],none,both are steps of evaluating patient with abnormal liver tests,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 02:51:20,1633502309,5/10/2015 02:51:01,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],HELLP SYNDROME RESULTS THROMBOCYTOPENIA PLATELETS third,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 03:00:35,1633504893,5/10/2015 02:59:56,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HELLP SYNDROME TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 03:56:00,1633519054,5/10/2015 03:54:33,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HELLP SYNDROME elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 04:52:19,1633531184,5/10/2015 04:51:41,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[SYMPTOM],[SYMPTOM],HELLP SYNDROME TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 06:56:55,1633557333,5/10/2015 06:55:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],clinical constellation,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 07:30:58,1633564207,5/10/2015 07:29:28,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],clinical,Symptoms,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 07:33:15,1633564706,5/10/2015 07:32:38,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 07:36:57,1633565348,5/10/2015 07:35:58,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],elevated liver TEST RESULTS,n/a,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911559,5/10/2015 08:06:25,1633570706,5/10/2015 08:05:17,false,prodege,1,27934334,GBR,C7,Coventry,109.150.225.5,[SYMPTOM],[SYMPTOM],clinical constellation,N/A,72,0,1,119,14,TWrex-cause,812816-FS1,"HELLP SYNDROME is a clinical constellation of hemolysis, elevated liver TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS  Usually occurs in the third trimester.",TEST RESULTS AND THROMBOCYTOPENIA (LOW PLATELETS,HELLP SYNDROME
717911560,5/9/2015 13:51:43,1633187038,5/9/2015 13:51:07,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],Reducing levels of copper,n/a,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:15:17,1633197115,5/9/2015 14:14:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Reducing,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:16:22,1633197594,5/9/2015 14:15:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],using,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:46:46,1633210883,5/9/2015 14:46:05,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[TREATS],[TREATS],WILSON'S DISEASE Reducing levels of copper in the body using TRIENTINE HYDROCHLORIDE,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:51:30,1633212849,5/9/2015 14:51:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Reducing levels,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:51:47,1633213000,5/9/2015 14:51:35,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",N/A,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 14:52:03,1633213058,5/9/2015 14:51:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Reducing levels,n/a,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:01:41,1633217268,5/9/2015 15:00:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TRIENTINE HYDROCHLORIDE Drug Adjusting medication,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:08:29,1633220346,5/9/2015 15:07:26,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],WILSON'S DISEASE Reducing levels of TRIENTINE HYDROCHLORIDE,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:28:38,1633228917,5/9/2015 15:27:50,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[TREATS],[TREATS],Reducing levels of copper in the body using,N/a,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:30:49,1633229814,5/9/2015 15:29:13,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Reducing levels,n/a,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:31:07,1633230055,5/9/2015 15:30:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],using,n/a,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:36:16,1633232336,5/9/2015 15:35:23,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],WILSON'S DISEASE Reducing levels of copper using TRIENTINE HYDROCHLORIDE,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:45:49,1633237018,5/9/2015 15:44:02,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Reducing levels using,treats  by reducing copper,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911560,5/9/2015 15:49:18,1633238589,5/9/2015 15:48:16,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[TREATS],[TREATS],using,N/A,0,80,-1,15,103,TWrex-cause,804880-FS1,"WILSON'S DISEASE Reducing levels of copper in the body using D penicillinamine, TRIENTINE HYDROCHLORIDE tetrathiomolybdate, and other chelating agents   Drug induced choreia Adjusting medication dosages.",WILSON'S DISEASE,TRIENTINE HYDROCHLORIDE
717911561,5/10/2015 00:23:21,1633453038,5/10/2015 00:22:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,n/a,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 00:26:18,1633453880,5/10/2015 00:25:28,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[CAUSES],[CAUSES],reported with use,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 00:49:58,1633461613,5/10/2015 00:47:33,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[CAUSES],[CAUSES],exacerbation preexisting diabetes,N/a,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 01:19:09,1633471601,5/10/2015 01:17:31,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SIDE_EFFECT],[SIDE_EFFECT],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.,n/a,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 01:41:22,1633478773,5/10/2015 01:40:29,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 01:47:22,1633480861,5/10/2015 01:44:55,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],has occurred.,n/a,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 01:50:19,1633481824,5/10/2015 01:49:46,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]",HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 02:13:39,1633489656,5/10/2015 02:11:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],Hyperglycemic HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS exacerbation preexisting diabetes mellitus PIs; DIABETIC KETOACIDOSIS occurred.,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 02:19:52,1633491814,5/10/2015 02:18:47,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[NONE],[NONE],n/a,"DIABETES MELLITUS is characterized by HYPERGLYCEMIA, it's not ""one long medical therm""",170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 02:48:37,1633501321,5/10/2015 02:46:51,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SIDE_EFFECT],[SIDE_EFFECT],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 02:55:02,1633503227,5/10/2015 02:54:28,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[MANIFESTATION],[MANIFESTATION],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 03:47:43,1633517063,5/10/2015 03:46:21,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],Hyperglycemic Effects HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 04:44:40,1633529409,5/10/2015 04:44:05,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[CAUSES],[CAUSES],HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS DIABETIC KETOACIDOSIS,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 06:44:24,1633554965,5/10/2015 06:43:08,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],occurred.,N/A,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911561,5/10/2015 07:22:20,1633562297,5/10/2015 07:21:01,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],occurred.,Occured,170,53,1,190,94,TWrex-cause,812385-FS1,"1 ,   4 ,   17 ,   23 ,   73  Hyperglycemic Effects  HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,HYPERGLYCEMIA NEW ONSET DIABETES MELLITUS
717911562,5/9/2015 19:45:24,1633344446,5/9/2015 19:44:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],TREATMENT,n/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 21:01:38,1633370507,5/9/2015 21:00:00,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],TREATMENT,n/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 21:59:11,1633391369,5/9/2015 21:58:34,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],TREATMENT,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 22:00:07,1633391707,5/9/2015 21:59:52,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],for,n/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 22:02:53,1633392746,5/9/2015 22:02:35,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 22:25:56,1633401433,5/9/2015 22:25:11,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],TREATMENT WITH,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 23:05:23,1633417892,5/9/2015 23:04:54,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],TREATMENT,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 23:28:30,1633428006,5/9/2015 23:28:04,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],TREATMENT WITH,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 23:47:38,1633436611,5/9/2015 23:46:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[NONE],[NONE],n/a,reuptake inhibitors,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/9/2015 23:50:53,1633438140,5/9/2015 23:50:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN for OBSESSIVE COMPULSIVE DISORDER,N/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/10/2015 00:13:27,1633448837,5/10/2015 00:11:57,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reuptake inhibitors,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/10/2015 00:36:56,1633457614,5/10/2015 00:36:14,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],TREATMENT,N/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/10/2015 00:48:19,1633461033,5/10/2015 00:47:10,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],TREATMENT,n/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/10/2015 00:56:26,1633463899,5/10/2015 00:55:54,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],COMBINATION TREATMENT reuptake inhibitors,n/a,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911562,5/10/2015 00:58:32,1633464640,5/10/2015 00:57:32,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],COMBINATION TREATMENT CLOMIPRAMINE SELECTIVE SEROTONIN reuptake inhibitors OBSESSIVE COMPULSIVE DISORDER,N/A,132,44,-1,160,107,TWrex-cause,800045-FS1,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN
717911563,5/9/2015 14:26:41,1633202288,5/9/2015 14:26:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],THERAPY for,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 14:48:46,1633211731,5/9/2015 14:47:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 14:59:14,1633216274,5/9/2015 14:58:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],during for,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 15:07:15,1633219744,5/9/2015 15:06:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],THERAPY for,n/a,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 15:26:25,1633227947,5/9/2015 15:25:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",Duration remission during relationship maintenance dose and degree improvement during initial therapy.,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 15:28:52,1633229054,5/9/2015 15:28:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS:,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 15:42:21,1633235147,5/9/2015 15:42:06,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],THERAPY for,n/a,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 15:51:10,1633239332,5/9/2015 15:49:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],THERAPY for,n/a,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 16:14:14,1633248939,5/9/2015 16:13:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for,is used for,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 16:19:00,1633250718,5/9/2015 16:17:53,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,PSORIASIS  is treated with  MAINTENANCE CYCLOSPORINE THERAPY,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 17:02:18,1633268044,5/9/2015 17:00:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],CYCLOSPORINE THERAPY,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 17:07:33,1633270121,5/9/2015 17:06:27,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS:,n/a,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 18:05:09,1633291879,5/9/2015 18:04:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS:,N/A,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 18:09:50,1633293503,5/9/2015 18:07:13,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[NONE],[NONE],N/a,It requires that treatment,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911563,5/9/2015 18:17:45,1633296466,5/9/2015 18:17:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],THERAPY for,n/a,106,69,1,114,101,TWrex-cause,815138-FS1,"Ellis CN, Fradin MS, Hamilton TA et al. Duration of remission during MAINTENANCE CYCLOSPORINE THERAPY for PSORIASIS: relationship to maintenance dose and degree of improvement during initial therapy.",PSORIASIS,MAINTENANCE CYCLOSPORINE THERAPY
717911564,5/9/2015 16:33:09,1633256108,5/9/2015 16:32:14,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ACNE VULGARIS is treated with  ERYTHROMYCIN,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 17:14:15,1633272489,5/9/2015 17:13:01,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],ACNE VULGARIS,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 17:15:10,1633272932,5/9/2015 17:14:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ERYTHROMYCIN used as treatment for ACNE VULGARIS,n/a,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 18:22:31,1633298241,5/9/2015 18:22:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],used primary treatment,n/a,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 18:39:37,1633304238,5/9/2015 18:38:43,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],primary or adjunctive treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 18:49:37,1633308832,5/9/2015 18:49:21,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 19:30:30,1633338735,5/9/2015 19:30:03,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 19:35:23,1633340852,5/9/2015 19:34:40,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ERYTHROMYCIN primary adjunctive treatment ACNE VULGARIS,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 20:30:13,1633359840,5/9/2015 20:28:28,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS] [SYMPTOM],"[TREATS]
[SYMPTOM]",used treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 21:42:24,1633385604,5/9/2015 21:40:20,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 21:51:43,1633388468,5/9/2015 21:51:11,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 21:53:00,1633388950,5/9/2015 21:52:35,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 22:02:00,1633392393,5/9/2015 22:01:17,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],ERYTHROMYCIN treatment for ACNE VULGARIS,n/a,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 22:31:13,1633403562,5/9/2015 22:29:40,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],primary or adjunctive treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911564,5/9/2015 22:45:05,1633409349,5/9/2015 22:43:09,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,85,24,-1,97,36,TWrex-cause,804127-FS1,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN
717911565,5/9/2015 18:27:08,1633299939,5/9/2015 18:26:40,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[SIDE_EFFECT],[SIDE_EFFECT],almost always occurs,n/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 18:49:14,1633308651,5/9/2015 18:48:25,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SYMPTOM],[SYMPTOM],those with,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 18:55:39,1633310947,5/9/2015 18:55:15,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],always occurs,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 19:39:56,1633342618,5/9/2015 19:39:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in those with,n/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 20:47:34,1633365814,5/9/2015 20:47:12,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[MANIFESTATION],[MANIFESTATION],occurs,n/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 21:53:33,1633389102,5/9/2015 21:52:23,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],occurs,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 21:56:27,1633390256,5/9/2015 21:56:10,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[MANIFESTATION],[MANIFESTATION],with,n/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 21:59:53,1633391604,5/9/2015 21:59:36,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 22:16:55,1633398055,5/9/2015 22:15:34,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],HEARING LOSS in those with NF2,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 22:57:13,1633414421,5/9/2015 22:56:35,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",in those with,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 23:19:09,1633423760,5/9/2015 23:18:15,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",Hearing Loss in NF2,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 23:36:42,1633431705,5/9/2015 23:35:43,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],NF2,n/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 23:45:11,1633435543,5/9/2015 23:43:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Because HEARING LOSS NF2,N/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/9/2015 23:54:08,1633439730,5/9/2015 23:51:51,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],patients do not always integrate,N/A,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911565,5/10/2015 00:26:59,1633454004,5/10/2015 00:25:40,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",always occurs after,N/a,49,36,1,60,39,TWrex-cause,813511-FS1,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2
717911566,5/9/2015 16:21:07,1633251344,5/9/2015 16:19:51,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],in populations where is widespread.,is existing there already,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 16:27:01,1633253811,5/9/2015 16:25:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,TUBERCULOSIS has no relation in that sentence to   LATENT TB,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 17:11:27,1633271309,5/9/2015 17:09:41,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],TUBERCULOSIS,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 17:11:43,1633271377,5/9/2015 17:11:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test to diagnose LATENT TB for TUBERCULOSIS,n/a,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 18:11:08,1633293875,5/9/2015 18:09:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using the test diagnose LATENT TB populations where empirical treatment for TUBERCULOSIS,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 18:20:36,1633297463,5/9/2015 18:19:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[SIDE_EFFECT],[SIDE_EFFECT],diagnose populations where empirical treatment,n/a,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 18:35:47,1633302839,5/9/2015 18:32:59,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[OTHER],[OTHER],implications,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 18:47:36,1633307989,5/9/2015 18:47:05,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 19:18:48,1633326597,5/9/2015 19:16:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],serious implications for using the test,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 19:27:09,1633337535,5/9/2015 19:26:35,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],diagnose,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 20:22:12,1633357126,5/9/2015 20:20:46,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS] [ASSOCIATED_WITH] [SIDE_EFFECT],"[TREATS]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",treatment,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 21:34:39,1633382834,5/9/2015 21:31:40,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[NONE],[NONE],N/A,I think there is not relation between those terms.,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 21:49:18,1633387755,5/9/2015 21:48:29,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[MANIFESTATION],[MANIFESTATION],implications,N/A,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 21:50:21,1633388008,5/9/2015 21:47:27,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[PREVENTS] [MANIFESTATION] [SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [OTHER] [NONE],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[OTHER]
[NONE]",sad,no,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911566,5/9/2015 21:56:29,1633390276,5/9/2015 21:53:35,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test to diagnose,n/a,131,76,-1,142,85,TWrex-cause,803039-FS1,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB
717911567,5/9/2015 13:51:06,1633186781,5/9/2015 13:50:27,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused by,n/a,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:14:33,1633196809,5/9/2015 14:14:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:15:10,1633197066,5/9/2015 14:14:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:44:33,1633209815,5/9/2015 14:43:48,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[CAUSES],[CAUSES],TRICHURIASIS caused by TRICHURIS TRICHIURA (whipworm.,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:51:12,1633212740,5/9/2015 14:50:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused by,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:51:32,1633212886,5/9/2015 14:51:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 14:51:33,1633212889,5/9/2015 14:51:09,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",N/A,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:00:40,1633216858,5/9/2015 14:58:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],caused TRICHURIS TRICHIURA,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:07:26,1633219781,5/9/2015 15:04:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CAUSES],[CAUSES],TRICHURIASIS caused by TRICHURIS TRICHIURA,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:27:49,1633228610,5/9/2015 15:27:12,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[CAUSES],[CAUSES],caused by,N/a,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:29:12,1633229194,5/9/2015 15:28:55,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:30:37,1633229748,5/9/2015 15:30:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:35:22,1633231918,5/9/2015 15:34:01,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],TRICHURIASIS caused by TRICHURIS TRICHIURA,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:43:19,1633235668,5/9/2015 15:41:53,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[CAUSES],[CAUSES],caused by,N/A,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911567,5/9/2015 15:43:54,1633236062,5/9/2015 15:42:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,the worm causes it,30,61,1,41,80,TWrex-cause,812425-FS1,9  Trichuriasis  Treatment of TRICHURIASIS   +    caused by  TRICHURIS TRICHIURA  (whipworm.,TRICHURIASIS,TRICHURIS TRICHIURA
717911568,5/9/2015 18:26:39,1633299789,5/9/2015 18:26:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],effective short term treatment,n/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 18:48:23,1633308297,5/9/2015 18:47:48,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],short term treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 18:55:15,1633310814,5/9/2015 18:54:50,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 19:39:11,1633342355,5/9/2015 19:38:57,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 20:43:52,1633364487,5/9/2015 20:43:22,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 21:52:21,1633388687,5/9/2015 21:51:53,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],effective treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 21:56:09,1633390095,5/9/2015 21:55:55,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],effective,n/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 21:59:34,1633391499,5/9/2015 21:59:13,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 22:15:33,1633397416,5/9/2015 22:15:03,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],PAROXETINE was found to be an effective treatment of PANIC DISORDER,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 22:56:34,1633414149,5/9/2015 22:56:10,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 23:18:14,1633423406,5/9/2015 23:17:54,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],short term treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 23:35:42,1633431267,5/9/2015 23:35:12,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 23:43:39,1633434872,5/9/2015 23:43:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],PAROXETINE treatment PANIC DISORDER,N/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/9/2015 23:51:46,1633438488,5/9/2015 23:50:14,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],found to be an effective and well tolerated short term treatment,N/A,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911568,5/10/2015 00:25:39,1633453709,5/10/2015 00:24:41,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,166,83,-1,179,93,TWrex-cause,800969-FS1,"• In a randomized, controlled trial of 425 patients with DSM III R panic disorder, PAROXETINE was found to be an effective and well tolerated short term treatment of PANIC DISORDER ( 81.",PANIC DISORDER,PAROXETINE
717911569,5/9/2015 14:27:02,1633202392,5/9/2015 14:26:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 14:51:06,1633212675,5/9/2015 14:48:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 14:59:30,1633216321,5/9/2015 14:59:15,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],and,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 15:08:27,1633220336,5/9/2015 15:07:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],and,two results that can occur,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 15:27:26,1633228402,5/9/2015 15:26:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [LOCATION],"[CAUSES]
[LOCATION]",VIRUS TO TARGET organs,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 15:29:57,1633229528,5/9/2015 15:28:54,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 15:44:40,1633236522,5/9/2015 15:42:22,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],resulting in and,n/a,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 15:52:30,1633239772,5/9/2015 15:51:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],and,n/a,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 16:15:48,1633249456,5/9/2015 16:14:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,both occur together,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 16:20:52,1633251307,5/9/2015 16:19:01,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,MAJOR' VIREMIA leads to  DISSEMINATION OF THE VIRUS TO TARGET,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 17:05:16,1633269217,5/9/2015 17:02:20,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],infection,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 17:08:27,1633270438,5/9/2015 17:07:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET,n/a,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 18:06:09,1633292248,5/9/2015 18:05:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs,N/A,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 18:10:42,1633293721,5/9/2015 18:09:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,And,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911569,5/9/2015 18:18:12,1633296597,5/9/2015 18:17:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,123,143,1,137,179,TWrex-cause,811180-FS1,"If viral replication is not contained by host defense mechanisms at this stage, symptomatic infection occurs, resulting in 'MAJOR' VIREMIA and DISSEMINATION OF THE VIRUS TO TARGET organs",'MAJOR' VIREMIA,DISSEMINATION OF THE VIRUS TO TARGET
717911570,5/9/2015 14:26:07,1633202133,5/9/2015 14:25:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is a chronic,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 14:47:39,1633211211,5/9/2015 14:45:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is a,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 14:58:58,1633216014,5/9/2015 14:58:36,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[IS_A],[IS_A],is a chronic,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 15:06:52,1633219638,5/9/2015 15:06:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],is a,n/a,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 15:25:11,1633227231,5/9/2015 15:23:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","chronic which collection liquid present middle ear space, there absence acute infection no perforation tympanic membrane is present.",N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 15:28:12,1633228756,5/9/2015 15:26:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[IS_A],[IS_A],OTITIS MEDIA WITH EFFUSION OME is a chronic INFLAMMATION OF THE MIDDLE EAR,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 15:42:04,1633235069,5/9/2015 15:41:48,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],is a,n/a,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 15:49:43,1633238720,5/9/2015 15:48:03,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],is a,n/a,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 16:12:32,1633248249,5/9/2015 16:11:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],is a,they are the same,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 16:17:52,1633250309,5/9/2015 16:15:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,INFLAMMATION OF THE MIDDLE EAR is called  OTITIS MEDIA WITH EFFUSION,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 17:00:49,1633267225,5/9/2015 17:00:28,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],INFLAMMATION,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 17:06:27,1633269702,5/9/2015 17:05:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],OTITIS MEDIA WITH EFFUSION is INFLAMMATION OF THE MIDDLE EAR,n/a,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 18:04:27,1633291630,5/9/2015 18:03:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],OTITIS MEDIA WITH EFFUSION OME is a chronic INFLAMMATION OF THE MIDDLE EAR,N/A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 18:07:13,1633292601,5/9/2015 18:06:03,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[IS_A],[IS_A],a,A,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911570,5/9/2015 18:17:09,1633296199,5/9/2015 18:16:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],a chronic,n/a,47,0,-1,76,26,TWrex-cause,802231-FS1,"OTITIS MEDIA WITH EFFUSION    OME is a chronic INFLAMMATION OF THE MIDDLE EAR in which a collection of liquid is present in the middle ear space, but there is an absence of acute infection and no perforation of the tympanic membrane is present.",INFLAMMATION OF THE MIDDLE EAR,OTITIS MEDIA WITH EFFUSION
717911571,5/10/2015 01:48:05,1633481116,5/10/2015 01:47:44,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES],[CAUSES],DIABETES INSIPIDUS VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 02:01:08,1633485688,5/10/2015 02:00:44,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[PREVENTS],[PREVENTS],DIABETES INSIPIDUS VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 02:33:00,1633496313,5/10/2015 02:31:42,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION],[MANIFESTATION],DIABETES INSIPIDUS may develop if less VASOPRESSIN is released,n/a,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 02:34:48,1633496867,5/10/2015 02:33:47,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],DIABETES INSIPIDUS may develop less VASOPRESSIN released hypothalamus compressed.,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 02:37:07,1633497558,5/10/2015 02:36:09,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"DIABETES INSIPIDUS may develop if less VASOPRESSIN is rel<span id=""transmark""></span>eased",I have not,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 02:54:15,1633503037,5/10/2015 02:53:49,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SIDE_EFFECT],[SIDE_EFFECT],DIABETES INSIPIDUS VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 03:04:37,1633506027,5/10/2015 03:03:46,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIABETES INSIPIDUS VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 04:01:21,1633520276,5/10/2015 04:00:44,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIABETES INSIPIDUS may develop if less VASOPRESSIN is released,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 04:58:08,1633532495,5/10/2015 04:57:28,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[CAUSES],[CAUSES],DIABETES INSIPIDUS VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 07:11:58,1633559985,5/10/2015 07:09:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],develop,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 07:37:35,1633565424,5/10/2015 07:36:31,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],develop,Develops because of,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 07:42:54,1633566425,5/10/2015 07:42:17,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[CAUSES],[CAUSES],may develop,n/a,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 07:55:47,1633568704,5/10/2015 07:55:23,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 08:40:35,1633577700,5/10/2015 08:38:43,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],less VASOPRESSIN,N/A,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911571,5/10/2015 08:50:40,1633579905,5/10/2015 08:49:46,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[SIDE_EFFECT],[SIDE_EFFECT],may develop,n/a,0,39,-1,17,50,TWrex-cause,803045-FS1,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN
717911572,5/9/2015 13:55:59,1633188876,5/9/2015 13:55:21,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[OTHER],[OTHER],did not improve,did not treat,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 14:19:42,1633199036,5/9/2015 14:19:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],did not improve,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 14:24:23,1633201155,5/9/2015 14:23:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],did not improve,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 14:53:22,1633213590,5/9/2015 14:53:04,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[LOCATION] [NONE],"[LOCATION]
[NONE]",N/A,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 14:54:10,1633213937,5/9/2015 14:53:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],did not improve,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 14:56:54,1633215042,5/9/2015 14:56:08,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],did not improve,n/a,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:11:00,1633221363,5/9/2015 15:09:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Medicine Rehabilitation Pain ACP,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:14:58,1633222902,5/9/2015 15:13:41,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:33:34,1633231147,5/9/2015 15:33:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],did not improve,n/a,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:35:29,1633232017,5/9/2015 15:34:46,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],did not improve,n/a,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:40:06,1633234248,5/9/2015 15:39:39,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:55:50,1633241245,5/9/2015 15:54:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,PAIN IN OSTEOARTHRITIS  is not relieved by   GLUCOSAMINE AND CHONDROITIN SULFATE,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 15:56:11,1633241440,5/9/2015 15:54:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[OTHER],[OTHER],did not improve,did not improve pain,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 16:16:45,1633249870,5/9/2015 16:16:02,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],did not improve,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911572,5/9/2015 16:37:24,1633257875,5/9/2015 16:35:52,false,instagc,1.0,22981457,CAN,ON,Kitchener,174.113.174.129,[CONTRAINDICATES],[CONTRAINDICATES],did not improve PAIN,N/A,52,0,-1,73,35,TWrex-cause,804016-FS1,"GLUCOSAMINE AND CHONDROITIN SULFATE did not improve PAIN IN OSTEOARTHRITIS of the knee  General Internal Medicine/Family Practitioner/General Practitioner Physical Medicine & Rehabilitation Rheumatology  About Star Ratings  Keywords: Chondroitin sulfates Glucosamine Osteoarthritis, knee Pain  ACP Journal Club.",PAIN IN OSTEOARTHRITIS,GLUCOSAMINE AND CHONDROITIN SULFATE
717911573,5/10/2015 01:48:24,1633481284,5/10/2015 01:48:07,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYPERSENSITIVITY NEOMYCIN,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 02:02:00,1633486001,5/10/2015 02:01:10,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",HYPERSENSITIVITY toxic reactions NEOMYCIN,n/a,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 02:35:05,1633496950,5/10/2015 02:33:00,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN,n/a,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 02:35:48,1633497139,5/10/2015 02:34:49,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",HYPERSENSITIVITY serious toxic reactions NEOMYCIN aminoglycosides.,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 02:38:06,1633497868,5/10/2015 02:37:09,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"HYPERSENSITIVITY reactions to NEO<span id=""transmark""></span>MYCIN",neomycin can cause toxic reactions including hypersensivity to this antibiotic,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 02:54:39,1633503115,5/10/2015 02:54:17,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[CAUSES],[CAUSES],HYPERSENSITIVITY NEOMYCIN,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 03:05:10,1633506213,5/10/2015 03:04:40,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[CONTRAINDICATES],[CONTRAINDICATES],HYPERSENSITIVITY NEOMYCIN,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 04:03:15,1633520803,5/10/2015 04:01:21,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Cautions Contraindications History of HYPERSENSITIVITY to NEOMYCIN,NA,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 05:00:03,1633532907,5/10/2015 04:58:10,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[NONE],[NONE],N/A,neomycin has no relation to hypersensitivity,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 07:12:57,1633560290,5/10/2015 07:12:00,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CONTRAINDICATES],[CONTRAINDICATES],Contraindications,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 07:38:07,1633565505,5/10/2015 07:37:37,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],reactions,Reacts,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 07:43:21,1633566464,5/10/2015 07:42:56,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[CAUSES],[CAUSES],toxic reactions,n/a,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 07:56:09,1633568807,5/10/2015 07:55:49,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 08:41:03,1633577835,5/10/2015 08:40:35,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],reactions to,N/A,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911573,5/10/2015 08:51:55,1633580120,5/10/2015 08:50:42,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CONTRAINDICATES],[CONTRAINDICATES],History or toxic reactions,n/a,52,99,1,67,107,TWrex-cause,811980-FS1,"1 ,   2  Cautions  Contraindications  •  History of HYPERSENSITIVITY or serious toxic reactions to NEOMYCIN or other aminoglycosides.",HYPERSENSITIVITY,NEOMYCIN
717911574,5/9/2015 23:10:29,1633420158,5/9/2015 23:09:49,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",EPIDEMIOLOGY,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/9/2015 23:53:59,1633439639,5/9/2015 23:53:27,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PART_OF],[PART_OF],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,N/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 00:19:44,1633451608,5/10/2015 00:18:36,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[LOCATION],[LOCATION],is found in,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 00:43:12,1633459499,5/10/2015 00:42:43,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PART_OF],[PART_OF],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,N/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 00:59:32,1633464864,5/10/2015 00:58:11,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PART_OF],[PART_OF],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,n/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 01:06:01,1633466979,5/10/2015 01:04:36,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[IS_A],[IS_A],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES is found in,n/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 01:08:31,1633467857,5/10/2015 01:06:35,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],LISTERIOSIS LISTERIA MONOCYTOGENES,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 01:37:31,1633477515,5/10/2015 01:36:41,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 01:42:37,1633479172,5/10/2015 01:41:47,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",LISTERIOSIS EPIDEMIOLOGY LISTERIA,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 02:10:36,1633488601,5/10/2015 02:08:28,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOC<span id=""transmark""></span>YTOGENES","LISTERIA MONOCYTOGENES causes LISTERIOSIS -it does not clearly appear in your sentence, it's a medical fact",0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 02:44:55,1633500210,5/10/2015 02:44:33,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[CAUSES],[CAUSES],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 02:50:46,1633502067,5/10/2015 02:49:51,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,y/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 03:04:39,1633506029,5/10/2015 03:04:00,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[IS_A],[IS_A],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,n/a,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 03:42:14,1633515562,5/10/2015 03:41:34,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],LISTERIOSIS LISTERIA MONOCYTOGENES,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911574,5/10/2015 04:36:56,1633527680,5/10/2015 04:34:02,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[PART_OF],[PART_OF],LISTERIOSIS EPIDEMIOLOGY LISTERIA MONOCYTOGENES,N/A,0,27,1,10,49,TWrex-cause,812036-FS1,"LISTERIOSIS  EPIDEMIOLOGY  LISTERIA MONOCYTOGENES  is found in soil, dust fertilizer, sewage, stream water, plants, processed foods, and the intestinal tract of many mammals.",LISTERIOSIS,LISTERIA MONOCYTOGENES
717911575,5/10/2015 01:47:14,1633480823,5/10/2015 01:46:49,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[SYMPTOM],[SYMPTOM],DRUG TOXICITY MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 02:00:05,1633485270,5/10/2015 01:59:32,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",DRUG TOXICITY premature discontinuation MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 02:02:59,1633486283,5/10/2015 02:01:59,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[NONE],[NONE],N/A,just no relationship without a real stretch,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 02:31:10,1633495688,5/10/2015 02:29:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT] [CAUSES] [TREATS],"[TREATS]
[CAUSES]
[SIDE_EFFECT]",Treatment failure DRUG TOXICITY premature discontinuation MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 02:35:03,1633496945,5/10/2015 02:34:15,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"DRUG TOXICITY cause MED<span id=""transmark""></span>ICATION",medications can cause drug toxicity,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 02:53:15,1633502817,5/10/2015 02:52:56,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SIDE_EFFECT],[SIDE_EFFECT],TOXICITY MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 03:03:21,1633505567,5/10/2015 03:02:28,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SYMPTOM],[SYMPTOM],DRUG TOXICITY MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 04:00:01,1633519998,5/10/2015 03:59:04,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",DRUG TOXICITY is sufficiently severe to cause premature discontinuation of MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 04:56:57,1633532238,5/10/2015 04:56:29,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[CAUSES],[CAUSES],DRUG TOXICITY MEDICATION,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 07:08:54,1633559379,5/10/2015 07:07:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Treatment,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 07:35:24,1633565089,5/10/2015 07:34:18,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],severe,Sever reaction,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 07:36:03,1633565196,5/10/2015 07:35:30,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 07:41:20,1633566017,5/10/2015 07:40:52,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[CAUSES],[CAUSES],sufficiently severe to cause,n/a,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 08:38:07,1633577297,5/10/2015 08:37:22,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],in patients,N/A,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911575,5/10/2015 08:49:00,1633579543,5/10/2015 08:47:36,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[SYMPTOM],[SYMPTOM],premature discontinuation,n/a,147,227,1,159,237,TWrex-cause,812157-FS1,"Evidence: • Treatment failure occurs in 9% of patients despite compliance with therapy, incomplete response occurs in 13% of treated patients, and DRUG TOXICITY that is sufficiently severe to cause premature discontinuation of MEDICATION occurs in 13% of patients ( 3 ;  152 ;  156.",DRUG TOXICITY,MEDICATION
717911576,5/9/2015 14:22:41,1633200474,5/9/2015 14:22:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],presenting,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 14:32:54,1633205056,5/9/2015 14:30:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",presenting acutely as,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 14:54:39,1633214091,5/9/2015 14:54:29,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[SIDE_EFFECT] [NONE],"[SIDE_EFFECT]
[NONE]",N/A,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 14:56:02,1633214740,5/9/2015 14:55:42,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],can lead to,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:00:44,1633216867,5/9/2015 15:00:08,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],presenting acutely as,n/a,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:16:13,1633223511,5/9/2015 15:15:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME",N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:21:05,1633225543,5/9/2015 15:20:12,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SYMPTOM],[SYMPTOM],WERNICKE KORSAKOFF SYNDROME presenting as ATAXIA,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:37:22,1633232852,5/9/2015 15:37:02,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[MANIFESTATION],[MANIFESTATION],presenting acutely,n/a,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:40:52,1633234524,5/9/2015 15:39:48,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],presenting acutely as,n/a,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 15:43:09,1633235529,5/9/2015 15:42:31,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],WERNICKE KORSAKOFF SYNDROME presenting acutely as ATAXIA,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 16:03:09,1633244813,5/9/2015 16:02:06,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],presenting,none,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 16:03:14,1633244860,5/9/2015 16:02:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],presenting,a symptom of,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 16:54:44,1633264695,5/9/2015 16:53:59,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],"ophthalmoplegia,",N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 17:00:26,1633267075,5/9/2015 16:59:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],WERNICKE KORSAKOFF SYNDROME presenting as ATAXIA,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911576,5/9/2015 17:56:49,1633289017,5/9/2015 17:55:22,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],WERNICKE KORSAKOFF SYNDROME presenting acutely ATAXIA,N/A,199,109,1,204,136,TWrex-cause,812951-FS1,"Rationale: • Lack of thiamine, combined with a relative state of poor nutrition postoperatively, can lead to WERNICKE KORSAKOFF SYNDROME presenting acutely as altered mental status, ophthalmoplegia, ATAXIA and memory disorders.",ATAXIA,WERNICKE KORSAKOFF SYNDROME
717911577,5/10/2015 00:24:57,1633453572,5/10/2015 00:24:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],OSTEOARTHRITIS RHEUMATOID ARTHRITIS ASPIRIN,n/a,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 00:32:57,1633456430,5/10/2015 00:30:26,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[OTHER],[OTHER],hypothetical,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 01:27:48,1633474420,5/10/2015 01:26:32,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[NONE],[NONE],N/A,"as they were NOT using the therapy, there is no indicator",65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 01:43:45,1633479542,5/10/2015 01:43:22,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],PATIENTS OSTEOARTHRITIS RHEUMATOID ARTHRITIS,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 01:54:12,1633483331,5/10/2015 01:51:35,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],taking,n/a,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 01:55:40,1633483799,5/10/2015 01:55:12,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS not taking ASPIRIN,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 02:18:29,1633491314,5/10/2015 02:17:06,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],OSTEOARTHRITIS RHEUMATOID ARTHRITIS taking ASPIRIN therapy arthritis pain.,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 02:24:49,1633493580,5/10/2015 02:23:33,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"patients with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS not taking AS<span id=""transmark""></span>PIRIN",nope,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 02:50:10,1633501892,5/10/2015 02:49:55,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[TREATS],[TREATS],PATIENTS OSTEOARTHRITIS RHEUMATOID,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 02:58:15,1633504234,5/10/2015 02:56:56,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SYMPTOM],[SYMPTOM],OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS ASPIRIN,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 03:52:35,1633518226,5/10/2015 03:51:55,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[NONE],[NONE],N/A,No relation,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 04:50:32,1633530709,5/10/2015 04:49:20,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[OTHER],[OTHER],OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS ASPIRIN,osteoarthritis or rheumatoid arthritis is treated with aspirin,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 06:51:48,1633556434,5/10/2015 06:50:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],not taking,N/A,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 07:28:07,1633563652,5/10/2015 07:26:22,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],hypothetical,Is a throry,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911577,5/10/2015 07:31:03,1633564220,5/10/2015 07:30:26,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[TREATS],[TREATS],moderate,n/a,65,124,-1,102,131,TWrex-cause,804812-FS1,PATIENTS  A hypothetical cohort of patients 60 years of age with OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS who were not taking ASPIRIN and required NSAID therapy for moderate to severe arthritis pain.,OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS,ASPIRIN
717911578,5/10/2015 00:22:30,1633452695,5/10/2015 00:21:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,n/a,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 00:24:28,1633453406,5/10/2015 00:23:29,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[CAUSES],[CAUSES],may precipitate an acute attack.,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 00:46:55,1633460523,5/10/2015 00:45:32,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",with may precipitate,N/a,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 01:14:39,1633470081,5/10/2015 01:12:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA dilation of the pupil,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 01:16:04,1633470506,5/10/2015 01:14:04,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM],[SYMPTOM],ANGLE CLOSURE In patients with ANGLE CLOSURE GLAUCOMA,n/a,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 01:39:35,1633478136,5/10/2015 01:39:04,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 01:43:29,1633479424,5/10/2015 01:41:05,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],patients with,n/a,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 01:48:59,1633481382,5/10/2015 01:48:24,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]",ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 02:14:54,1633490120,5/10/2015 02:13:59,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"ACUTE ANGLE CLOSURE In ANGLE CLOSURE GLAUCOMA may precipitate att<span id=""transmark""></span>ack.",have not,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 02:46:27,1633500706,5/10/2015 02:46:08,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 02:53:58,1633502967,5/10/2015 02:53:09,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[TREATS],[TREATS],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,n/a,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 03:45:22,1633516425,5/10/2015 03:44:23,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 04:43:22,1633529105,5/10/2015 04:42:50,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[PART_OF],[PART_OF],ACUTE ANGLE CLOSURE ANGLE CLOSURE GLAUCOMA,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 06:41:29,1633554514,5/10/2015 06:39:12,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],In,N/A,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911578,5/10/2015 07:19:56,1633561848,5/10/2015 07:19:05,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],with,With,0,38,1,18,60,TWrex-cause,813645-FS1,ACUTE ANGLE CLOSURE  In patients with ANGLE CLOSURE GLAUCOMA dilation of the pupil may precipitate an acute attack.,ACUTE ANGLE CLOSURE,ANGLE CLOSURE GLAUCOMA
717911579,5/9/2015 13:47:34,1633185356,5/9/2015 13:45:15,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],with,n/a,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:07:13,1633193910,5/9/2015 14:05:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],controlled trial,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:13:22,1633196342,5/9/2015 14:12:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],controlled trial,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:41:05,1633208470,5/9/2015 14:40:13,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[TREATS],[TREATS],"LOW DOSE METHYLPHENIDATE in children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:49:35,1633212101,5/9/2015 14:48:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],trial in,n/a,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:49:37,1633212115,5/9/2015 14:49:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],trial,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:50:38,1633212526,5/9/2015 14:50:24,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",N/A,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:53:44,1633213741,5/9/2015 14:52:33,false,instagc,1.0,19740138,CAN,"","",50.69.96.237,[TREATS],[TREATS],controlled trial,n/a,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 14:56:08,1633214767,5/9/2015 14:54:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"DOSE METHYLPHENIDATE disorder,",N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:02:26,1633217615,5/9/2015 15:01:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],LOW DOSE METHYLPHENIDATE was superior to either agent alone.,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:24:53,1633227054,5/9/2015 15:23:59,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[TREATS],[TREATS],combination therapy was superior to either agent alone.,N/a,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:26:08,1633227807,5/9/2015 15:25:28,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],therapy,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:29:13,1633229206,5/9/2015 15:28:23,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],trial with,n/a,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:32:38,1633230737,5/9/2015 15:32:18,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],controlled trial of LOW DOSE METHYLPHENIDATE with ADHD combination therapy was superior to either agent alone.,N/A,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911579,5/9/2015 15:37:27,1633232887,5/9/2015 15:34:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,treats  better when combined with other drug,104,53,-1,107,77,TWrex-cause,800699-FS1,"• In a randomized, controlled trial of clonidine and LOW DOSE METHYLPHENIDATE in 136 children with both ADHD and chronic tic disorder, combination therapy was superior to either agent alone.",ADHD,LOW DOSE METHYLPHENIDATE
717911580,5/9/2015 18:55:40,1633310951,5/9/2015 18:55:18,false,elite,1,30064988,GBR,"","",89.241.94.221,[PREVENTS],[PREVENTS],preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 18:58:46,1633311927,5/9/2015 18:58:33,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 19:44:19,1633344068,5/9/2015 19:44:05,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],preventing,n/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 20:58:22,1633369521,5/9/2015 20:57:48,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],preventing,n/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 21:58:07,1633390872,5/9/2015 21:57:50,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[PREVENTS],[PREVENTS],preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 21:59:29,1633391468,5/9/2015 21:59:13,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],preventing,n/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 22:02:17,1633392516,5/9/2015 22:02:03,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 22:24:45,1633401089,5/9/2015 22:23:35,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],for preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 23:04:20,1633417519,5/9/2015 23:03:54,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PREVENTS],[PREVENTS],preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 23:27:21,1633427580,5/9/2015 23:26:42,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 23:45:36,1633435744,5/9/2015 23:45:07,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],preventing,n/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/9/2015 23:49:34,1633437539,5/9/2015 23:49:15,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],vsUNFRACTIONATED HEPARIN preventing VTE,N/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/10/2015 00:11:06,1633447765,5/10/2015 00:09:34,false,points4rewards,1,28703583,USA,"","",97.73.94.14,[PREVENTS],[PREVENTS],for preventing,N/A,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/10/2015 00:34:53,1633456985,5/10/2015 00:34:27,false,getpaid,1,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],preventing,N/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911580,5/10/2015 00:46:16,1633460312,5/10/2015 00:45:30,false,clixsense,1,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],preventing,n/a,107,69,-1,109,91,TWrex-cause,804815-FS1,• A meta analysis showed that the efficacy and safety of enoxaprin vsUNFRACTIONATED HEPARIN for preventing VTE is not affected by the presence of symptomatic PE.,VTE,UNFRACTIONATED HEPARIN
717911581,5/9/2015 16:32:12,1633255842,5/9/2015 16:30:43,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],may range,none,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 17:13:00,1633271897,5/9/2015 17:12:37,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],diarrhea colitis,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 17:14:39,1633272629,5/9/2015 17:13:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],diarrhea also known ANTIBIOTIC ASSOCIATED DIARRHEA,n/a,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 18:22:13,1633298118,5/9/2015 18:21:39,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],range in severity,n/a,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 18:38:40,1633303807,5/9/2015 18:37:56,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SYMPTOM],[SYMPTOM],MILD DIARRHEA,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 18:49:20,1633308680,5/9/2015 18:48:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],known as,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 19:30:02,1633338583,5/9/2015 19:29:37,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],reported,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 19:34:39,1633340563,5/9/2015 19:33:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH] [SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",ANTIBIOTIC ASSOCIATED DIARRHEA MILD DIARRHEA,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 20:28:27,1633359049,5/9/2015 20:27:37,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH] [OTHER] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]",associated,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 21:40:18,1633384961,5/9/2015 21:38:07,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[NONE],[NONE],N/A,I think there's no relation between those terms,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 21:51:11,1633388301,5/9/2015 21:50:33,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[SYMPTOM],[SYMPTOM],reported,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 21:52:33,1633388771,5/9/2015 21:52:14,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 22:01:16,1633392102,5/9/2015 21:59:17,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],ANTIBIOTIC ASSOCIATED DIARRHEA may range in severity from MILD DIARRHEA,n/a,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 22:29:39,1633402852,5/9/2015 22:28:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],reported,N/A,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911581,5/9/2015 22:44:07,1633408902,5/9/2015 22:42:54,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],diarrhea colitis,n/a,296,122,1,308,152,TWrex-cause,814738-FS1,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
717911582,5/10/2015 01:40:57,1633478614,5/10/2015 01:40:14,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[OTHER],[OTHER],disorder that somewhat resembles,n/a,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 01:46:26,1633480535,5/10/2015 01:45:59,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[SYMPTOM],[SYMPTOM],MARCH HEMOGLOBINURIA MICROANGIOPATHIC HEMOLYSIS,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 01:58:59,1633484841,5/10/2015 01:58:27,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MARCH HEMOGLOBINURIA somewhat resembles MICROANGIOPATHIC HEMOLYSIS,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 02:28:26,1633494854,5/10/2015 02:26:46,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[OTHER],[OTHER],resembles,resembles was the best answer,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 02:33:19,1633496402,5/10/2015 02:31:59,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"MARCH HEMOGLOBINURIA resembles MICROANGIOPATHIC HEMO<span id=""transmark""></span>LYSIS",not none,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 02:52:22,1633502583,5/10/2015 02:52:01,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],MARCH HEMOGLOBINURIA MICROANGIOPATHIC HEMOLYSIS,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 03:01:59,1633505239,5/10/2015 03:01:36,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[CAUSES],[CAUSES],MARCH HEMOGLOBINURIA MICROANGIOPATHIC HEMOLYSIS,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 03:57:58,1633519519,5/10/2015 03:57:11,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[OTHER],[OTHER],MARCH HEMOGLOBINURIA somewhat resembles MICROANGIOPATHIC HEMOLYSIS,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 04:55:25,1633531876,5/10/2015 04:53:24,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[NONE],[NONE],microangiopathic hemolysis resembles march hemoglobinuria,resembles,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 07:05:54,1633558831,5/10/2015 07:03:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],resembles,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 07:33:34,1633564749,5/10/2015 07:32:55,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],resembles,Similar to,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 07:35:10,1633565072,5/10/2015 07:34:30,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 07:40:23,1633565890,5/10/2015 07:39:07,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,[NONE],[NONE],n/a,they are similar to each other and I there is no option for that.,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 08:36:53,1633577104,5/10/2015 08:35:54,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],somewhat resembles,N/A,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911582,5/10/2015 08:46:44,1633579051,5/10/2015 08:45:47,false,clixsense,1,6330007,AUS,06,Hobart,101.178.23.54,[NONE],[NONE],n/a,only a resemblence to each other,78,22,1,103,42,TWrex-cause,813805-FS1,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA
717911583,5/9/2015 18:53:52,1633310247,5/9/2015 18:53:14,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],treatment,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 18:57:52,1633311686,5/9/2015 18:57:37,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 19:43:21,1633343765,5/9/2015 19:42:23,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 20:55:41,1633368648,5/9/2015 20:54:49,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],treatment,n/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 21:57:05,1633390493,5/9/2015 21:56:49,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],treatment,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 21:58:57,1633391277,5/9/2015 21:58:36,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],shown efficacy treatment,n/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 22:01:44,1633392265,5/9/2015 22:01:29,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 22:21:55,1633399975,5/9/2015 22:21:04,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],RATIONALE INTRALESIONAL VINBLASTINE has shown efficacy for the treatment in patients with AIDS ASSOCIATED KS,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 23:01:32,1633416338,5/9/2015 23:01:13,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 23:25:59,1633426954,5/9/2015 23:25:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the treatment of,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 23:43:37,1633434877,5/9/2015 23:42:13,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/9/2015 23:48:49,1633437135,5/9/2015 23:48:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],RATIONALE INTRALESIONAL VINBLASTINE treatment AIDS ASSOCIATED KS,N/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/10/2015 00:07:54,1633446424,5/10/2015 00:06:35,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],has shown efficacy for the treatment of oral or cutaneous KS lesions,N/A,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/10/2015 00:33:28,1633456549,5/10/2015 00:32:17,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911583,5/10/2015 00:43:09,1633459484,5/10/2015 00:41:41,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],efficacy for the treatment,n/a,124,0,-1,141,37,TWrex-cause,804266-FS1,RATIONALE • INTRALESIONAL VINBLASTINE has shown efficacy for the treatment of oral or cutaneous KS lesions in patients with AIDS ASSOCIATED KS,AIDS ASSOCIATED KS,RATIONALE • INTRALESIONAL VINBLASTINE
717911584,5/9/2015 16:34:34,1633256632,5/9/2015 16:33:10,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ACTINOMYCOSIS is caused by   ACTINOMYCES ISRAELII,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 17:15:38,1633273094,5/9/2015 17:14:18,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],ACTINOMYCES ISRAELII.,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 17:15:45,1633273131,5/9/2015 17:15:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],ACTINOMYCOSIS caused by ACTINOMYCES ISRAELII.,n/a,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 18:22:46,1633298339,5/9/2015 18:22:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment of,n/a,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 18:40:08,1633304482,5/9/2015 18:39:39,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[CAUSES],[CAUSES],caused by,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 18:49:53,1633308908,5/9/2015 18:49:38,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 19:31:00,1633338954,5/9/2015 19:30:32,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused by,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 19:35:55,1633341065,5/9/2015 19:35:25,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],ACTINOMYCOSIS caused by ACTINOMYCES ISRAELII.,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 20:31:29,1633360166,5/9/2015 20:30:14,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],caused,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 21:43:04,1633385799,5/9/2015 21:42:25,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],Treatment,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 21:52:01,1633388579,5/9/2015 21:51:44,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],caused,n/a,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 21:53:18,1633389019,5/9/2015 21:53:03,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[PREVENTS] [SYMPTOM] [NONE],"[PREVENTS]
[SYMPTOM]
[NONE]",no,no,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 22:02:34,1633392647,5/9/2015 22:02:01,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],ACTINOMYCOSIS caused ACTINOMYCES ISRAELII.,n/a,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 22:32:01,1633403951,5/9/2015 22:31:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of,N/A,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911584,5/9/2015 22:44:53,1633409307,5/9/2015 22:44:08,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],ACTINOMYCOSIS,n/a,31,56,1,43,76,TWrex-cause,811350-FS1,a  Actinomycosis  Treatment of ACTINOMYCOSIS caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
717911585,5/9/2015 13:52:08,1633187123,5/9/2015 13:51:44,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],suggest,n/a,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:16:39,1633197721,5/9/2015 14:15:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",suggest,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:17:14,1633198023,5/9/2015 14:16:26,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:47:45,1633211307,5/9/2015 14:46:49,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[SYMPTOM],[SYMPTOM],WELL FORMED VISUAL HALLUCINATIONS suggest LEWY BODY DEMENTIA,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:51:57,1633213056,5/9/2015 14:51:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],suggest,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:51:59,1633213057,5/9/2015 14:51:49,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[CAUSES] [NONE],"[CAUSES]
[NONE]",N/A,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 14:52:46,1633213355,5/9/2015 14:52:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],suggest,n/a,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:02:50,1633217754,5/9/2015 15:01:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"parkinsonian symptoms,",N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:10:26,1633221136,5/9/2015 15:08:31,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SYMPTOM],[SYMPTOM],WELL FORMED VISUAL HALLUCINATIONS suggest LEWY BODY DEMENTIA,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:29:40,1633229446,5/9/2015 15:28:39,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest,N/a,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:31:06,1633230046,5/9/2015 15:30:51,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],suggest,n/a,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:31:31,1633230249,5/9/2015 15:31:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],suggest,n/a,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:36:56,1633232625,5/9/2015 15:36:18,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],WELL FORMED VISUAL HALLUCINATIONS suggest LEWY BODY DEMENTIA,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:48:10,1633238102,5/9/2015 15:45:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],suggest,is a symptom,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911585,5/9/2015 15:48:15,1633238109,5/9/2015 15:45:36,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[SYMPTOM],[SYMPTOM],suggest,N/A,50,139,1,82,157,TWrex-cause,813253-FS1,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA
717911586,5/10/2015 01:46:47,1633480596,5/10/2015 01:46:28,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BALANTIDIASIS BALANTIDIUM COLI,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 01:56:29,1633484160,5/10/2015 01:55:55,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],BALANTIDIASIS + caused by BALANTIDIUM COLI,n/a,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 01:59:30,1633485030,5/10/2015 01:59:00,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[CAUSES],[CAUSES],Balantidiasis BALANTIDIASIS caused by BALANTIDIUM COLI,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 02:29:48,1633495250,5/10/2015 02:28:30,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Balantidiasis Treatment BALANTIDIASIS caused BALANTIDIUM COLI drug of choice.,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 02:34:12,1633496651,5/10/2015 02:33:21,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"BALANTIDIASIS caused by BALANTIDIUM C<span id=""transmark""></span>OLI",Balantidium causes Balantidiasis,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 02:52:54,1633502691,5/10/2015 02:52:24,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Balantidiasis BALANTIDIASIS BALANTIDIUM,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 03:02:26,1633505329,5/10/2015 03:02:02,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BALANTIDIASIS BALANTIDIUM COLI,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 03:59:02,1633519780,5/10/2015 03:57:59,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[OTHER],[OTHER],BALANTIDIASIS caused by BALANTIDIUM COLI,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 04:56:27,1633532139,5/10/2015 04:55:26,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[CAUSES],[CAUSES],BALANTIDIASIS BALANTIDIUM COLI,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 07:07:19,1633559059,5/10/2015 07:05:55,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 07:34:17,1633564910,5/10/2015 07:33:35,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],caused,Caused by,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 07:35:28,1633565106,5/10/2015 07:35:12,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 07:40:51,1633565935,5/10/2015 07:40:24,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[CAUSES],[CAUSES],caused by,n/a,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 08:37:22,1633577150,5/10/2015 08:36:54,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],caused by,N/A,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911586,5/10/2015 08:47:33,1633579252,5/10/2015 08:46:47,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES],[CAUSES],caused by,n/a,47,79,1,59,95,TWrex-cause,812164-FS1,"122 ,   123 ,   i  Balantidiasis  Treatment of BALANTIDIASIS   +    caused by  BALANTIDIUM COLI ; drug of choice.",BALANTIDIASIS,BALANTIDIUM COLI
717911587,5/9/2015 14:24:30,1633201283,5/9/2015 14:23:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],should be considered,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 14:41:59,1633208735,5/9/2015 14:39:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],should be considered to have,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 14:57:54,1633215513,5/9/2015 14:57:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],should be considered to have,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:05:21,1633218966,5/9/2015 15:03:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],should be considered to have,n/a,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:21:09,1633225554,5/9/2015 15:19:54,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],LYMPHADENOPATHY hepatosplenomegaly should considered have the SMALL LYMPHOCYTIC LYMPHOMA,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:25:13,1633227274,5/9/2015 15:24:01,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Those who have LYMPHADENOPATHY should be considered to have SMALL LYMPHOCYTIC LYMPHOMA,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:40:58,1633234540,5/9/2015 15:39:56,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],should be considered to have,n/a,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:45:13,1633236791,5/9/2015 15:44:10,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],should be considered to have,n/a,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 15:45:35,1633236896,5/9/2015 15:44:55,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],Those who have LYMPHADENOPATHY should be considered to have SMALL LYMPHOCYTIC LYMPHOMA,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 16:08:33,1633246727,5/9/2015 16:07:26,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],considered to have,is a  type of,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 16:13:02,1633248465,5/9/2015 16:12:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,SMALL LYMPHOCYTIC LYMPHOMA (SLL) is present in LYMPHADENOPATHY,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 16:58:42,1633266379,5/9/2015 16:58:12,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],hepatosplenomegaly,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 17:03:30,1633268529,5/9/2015 17:02:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who do have LYMPHADENOPATHY should be considered to have SMALL LYMPHOCYTIC LYMPHOMA,n/a,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 18:01:37,1633290530,5/9/2015 18:00:31,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",LYMPHADENOPATHY considered have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant CLL.,N/A,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911587,5/9/2015 18:01:47,1633290670,5/9/2015 18:00:05,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],have,Have,62,133,1,76,159,TWrex-cause,813771-FS1,Those with a B cell count less than 5×10 9 /L but who do have LYMPHADENOPATHY or hepatosplenomegaly should be considered to have the SMALL LYMPHOCYTIC LYMPHOMA (SLL) variant of CLL.,LYMPHADENOPATHY,SMALL LYMPHOCYTIC LYMPHOMA
717911588,5/9/2015 13:56:31,1633189186,5/9/2015 13:55:59,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[OTHER],[OTHER],may not have an effect,no effect,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 14:20:06,1633199187,5/9/2015 14:19:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],may not have an effect,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 14:25:00,1633201547,5/9/2015 14:24:28,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],may not have an effect on,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 14:53:40,1633213679,5/9/2015 14:53:24,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[CONTRAINDICATES] [NONE],"[CONTRAINDICATES]
[NONE]",N/A,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 14:54:28,1633214023,5/9/2015 14:54:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],may not have an effect on,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 14:57:34,1633215456,5/9/2015 14:56:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],may not have an effect on,n/a,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:12:07,1633221856,5/9/2015 15:11:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],Another review suggests ISOPROTERENOL,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:16:07,1633223433,5/9/2015 15:14:59,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CONTRAINDICATES],[CONTRAINDICATES],ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:34:34,1633231543,5/9/2015 15:33:35,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],may not have an effect on,n/a,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:35:46,1633232089,5/9/2015 15:35:30,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],may not have an effect,n/a,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:40:31,1633234421,5/9/2015 15:40:07,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:57:16,1633241904,5/9/2015 15:55:51,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,VASOVAGAL SYNCOPE is not helped by ISOPROTERENOL,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 15:58:07,1633242289,5/9/2015 15:56:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[OTHER],[OTHER],may not have an effect,no effect,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 16:17:37,1633250206,5/9/2015 16:16:47,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],may not have an effect,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911588,5/9/2015 16:38:30,1633258319,5/9/2015 16:37:25,false,instagc,1,22981457,CAN,ON,Kitchener,174.113.174.129,[OTHER],[OTHER],may not have an effect on,N/A,71,31,-1,87,44,TWrex-cause,803057-FS1,• Another review suggests that ISOPROTERENOL may not have an effect on VASOVAGAL SYNCOPE during upright tilt testing ( 14.,VASOVAGAL SYNCOPE,ISOPROTERENOL
717911589,5/9/2015 14:28:24,1633202905,5/9/2015 14:27:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 14:53:28,1633213602,5/9/2015 14:52:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 14:59:59,1633216588,5/9/2015 14:59:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 15:09:24,1633220750,5/9/2015 15:08:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],caused by and,two causes,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 15:29:44,1633229493,5/9/2015 15:28:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 15:32:06,1633230564,5/9/2015 15:30:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION;,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 15:45:50,1633237020,5/9/2015 15:45:05,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],and,n/a,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 15:55:51,1633241259,5/9/2015 15:54:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[OTHER],[OTHER],and,n/a,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 16:18:41,1633250630,5/9/2015 16:16:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,both are causes,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 16:23:32,1633252228,5/9/2015 16:22:00,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,RESPIRATORY SYNCYTIAL VIRUS (RSV)  as well as PARAINFLUENZA 3 VIRUS INFECTION,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 17:09:15,1633270685,5/9/2015 17:07:09,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],RESPIRATORY SYNCYTIAL VIRUS,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 17:10:12,1633270993,5/9/2015 17:09:26,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],RESPIRATORY SYNCYTIAL VIRUS and PARAINFLUENZA 3 VIRUS INFECTION;,n/a,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 18:08:26,1633293063,5/9/2015 18:07:12,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION;,N/A,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 18:19:27,1633297039,5/9/2015 18:19:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911589,5/9/2015 18:26:51,1633299834,5/9/2015 18:24:44,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[NONE],[NONE],N/A,Talking about bronchiolitis in these two separate incidences,157,119,1,187,146,TWrex-cause,810023-FS1,"Bronchiolitis often occurs in epidemics and mostly in children  Etiology and Pathophysiology  Most cases are caused by RESPIRATORY SYNCYTIAL VIRUS (RSV) and PARAINFLUENZA 3 VIRUS INFECTION; less frequent causes are influenza A and B, parainfluenza 1 and 2, metapneumovirus, and adenoviruses.",PARAINFLUENZA 3 VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS
717911590,5/10/2015 01:47:42,1633481004,5/10/2015 01:47:16,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES],[CAUSES],GANCICLOVIR PROPHYLAXIS CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 02:00:42,1633485489,5/10/2015 02:00:06,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[PREVENTS],[PREVENTS],GANCICLOVIR PROPHYLAXIS can prevent development of CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 02:31:41,1633495913,5/10/2015 02:31:01,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[PREVENTS],[PREVENTS],GANCICLOVIR PROPHYLAXIS beginning time of engraftment can prevent CMV INFECTION,n/a,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 02:32:38,1633496213,5/10/2015 02:31:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS] [CAUSES],"[PREVENTS]
[CAUSES]",GANCICLOVIR PROPHYLAXIS can prevent development CMV INFECTION ganciclovir causes significant marrow suppression,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 02:36:07,1633497197,5/10/2015 02:35:05,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[PREVENTS],[PREVENTS],"GANCICLOVIR PROPHYLAXIS can prevent CMV INFE<span id=""transmark""></span>CTION",no I not,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 02:53:46,1633502900,5/10/2015 02:53:19,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GANCICLOVIR PROPHYLAXIS CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 03:03:44,1633505687,5/10/2015 03:03:23,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[CAUSES],[CAUSES],GANCICLOVIR PROPHYLAXIS CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 04:00:43,1633520115,5/10/2015 04:00:02,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[PREVENTS],[PREVENTS],GANCICLOVIR PROPHYLAXIS can prevent CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 04:57:28,1633532322,5/10/2015 04:56:57,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[PREVENTS],[PREVENTS],GANCICLOVIR PROPHYLAXIS CMV INFECTION,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 07:09:38,1633559551,5/10/2015 07:08:55,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevent,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 07:36:28,1633565255,5/10/2015 07:36:05,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[PREVENTS],[PREVENTS],prevent,n/a,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 07:36:30,1633565259,5/10/2015 07:35:25,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],prevent,Preventative measure,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 07:42:16,1633566240,5/10/2015 07:41:21,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[PREVENTS],[PREVENTS],can prevent,n/a,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 08:38:42,1633577357,5/10/2015 08:38:08,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],can prevent,N/A,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911590,5/10/2015 08:49:44,1633579684,5/10/2015 08:49:02,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[PREVENTS],[PREVENTS],can prevent,n/a,92,0,-1,104,23,TWrex-cause,804545-FS1,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS
717911591,5/9/2015 14:22:01,1633200079,5/9/2015 14:21:21,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 14:30:13,1633203689,5/9/2015 14:27:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],Symptoms,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 14:54:27,1633214025,5/9/2015 14:54:16,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",N/A,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 14:55:41,1633214624,5/9/2015 14:55:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],"more intense, lasts longer,",N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:00:07,1633216638,5/9/2015 14:58:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:14:58,1633222895,5/9/2015 15:14:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],Symptoms are those of angina pectoris,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:20:10,1633225231,5/9/2015 15:19:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SYMPTOM],[SYMPTOM],PAIN occurs (as ANGINA DECUBITUS,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:37:00,1633232655,5/9/2015 15:36:30,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],Symptoms,n/a,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:39:47,1633234109,5/9/2015 15:38:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],Symptoms,n/a,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 15:42:30,1633235228,5/9/2015 15:41:23,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],Symptoms are PAIN is ANGINA DECUBITUS,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 16:02:04,1633244407,5/9/2015 16:00:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],occurs,a symptom of angina,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 16:02:05,1633244408,5/9/2015 15:59:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],occurs spontaneously,none,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 16:53:58,1633264262,5/9/2015 16:52:03,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],PAIN,N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 16:58:42,1633266377,5/9/2015 16:56:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],"Symptoms of angina pectoris PAIN is more intense,",N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911591,5/9/2015 17:55:20,1633288427,5/9/2015 17:52:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],"Symptoms are those of angina pectoris the PAIN unstable angina usually more intense,",N/A,100,244,1,103,260,TWrex-cause,813896-FS1,"Unstable angina:  Symptoms are those of angina pectoris (see  Symptoms and Signs ), except that the PAIN or discomfort of unstable angina usually is more intense, lasts longer, is precipitated by less exertion, occurs spontaneously at rest (as ANGINA DECUBITUS is progressive (crescendo) in nature, or involves any combination of these features.",PAIN,ANGINA DECUBITUS
717911592,5/9/2015 17:16:31,1633273431,5/9/2015 17:16:11,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],(WHOOPING COUGH),N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 17:17:24,1633273845,5/9/2015 17:16:46,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PERTUSSIS (WHOOPING COUGH) caused by BORDETELLA PERTUSSIS,n/a,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 18:23:19,1633298508,5/9/2015 18:23:05,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 18:41:01,1633304826,5/9/2015 18:40:38,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[CAUSES],[CAUSES],caused by,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 18:50:25,1633309134,5/9/2015 18:50:11,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 19:31:46,1633339290,5/9/2015 19:31:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused by,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 19:37:06,1633341606,5/9/2015 19:36:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],(WHOOPING COUGH) caused by BORDETELLA PERTUSSIS,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 20:32:44,1633360618,5/9/2015 20:32:15,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],caused,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 21:44:14,1633386148,5/9/2015 21:43:41,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],caused by,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 21:52:34,1633388770,5/9/2015 21:52:21,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],caused,n/a,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 21:54:06,1633389392,5/9/2015 21:53:40,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 22:03:31,1633392959,5/9/2015 22:03:07,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],PERTUSSIS (WHOOPING COUGH) caused BORDETELLA PERTUSSIS,n/a,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 22:33:15,1633404424,5/9/2015 22:32:52,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],infection caused by,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 22:45:31,1633409597,5/9/2015 22:45:06,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[CAUSES],[CAUSES],caused,N/A,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911592,5/9/2015 23:22:41,1633425392,5/9/2015 23:22:15,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,13,91,1,38,111,TWrex-cause,810024-FS1,"198 ,   199  PERTUSSIS (WHOOPING COUGH) is an acute respiratory tract infection caused by  BORDETELLA PERTUSSIS",PERTUSSIS (WHOOPING COUGH),BORDETELLA PERTUSSIS
717911593,5/9/2015 17:22:13,1633275685,5/9/2015 17:20:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],MALARIA is due to DOXYCYCLINE,n/a,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 17:23:15,1633276089,5/9/2015 17:21:37,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],MALARIA,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 18:24:57,1633299166,5/9/2015 18:24:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],recommended.,n/a,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 18:45:00,1633306747,5/9/2015 18:44:31,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 18:52:27,1633309848,5/9/2015 18:52:03,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],due to,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 19:35:34,1633340915,5/9/2015 19:34:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],recommended.,n/a,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 19:42:25,1633343390,5/9/2015 19:41:46,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],MALARIA DOXYCYCLINE may be recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 20:37:16,1633362253,5/9/2015 20:36:26,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 21:47:34,1633387241,5/9/2015 21:46:57,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[PREVENTS],[PREVENTS],recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 21:54:38,1633389564,5/9/2015 21:54:16,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],recommended.,n/a,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 21:56:09,1633390086,5/9/2015 21:55:50,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [PREVENTS] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 22:07:46,1633394689,5/9/2015 22:07:12,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],MALARIA is due to DOXYCYCLINE,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 22:52:17,1633412155,5/9/2015 22:50:28,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 22:52:46,1633412427,5/9/2015 22:50:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],may be recommended.,N/A,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911593,5/9/2015 23:26:30,1633427174,5/9/2015 23:25:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],recommended.,n/a,46,130,-1,52,141,TWrex-cause,804427-FS1,"For nonimmune people traveling in areas where MALARIA is due to chloroquine resistant  P. falciparum  and  P. vivax , mefloquine, DOXYCYCLINE or atovaquone plus proguanil hydrochloride may be recommended.",MALARIA,DOXYCYCLINE
717911594,5/9/2015 18:27:26,1633300023,5/9/2015 18:27:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs after,n/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 18:50:13,1633309098,5/9/2015 18:49:15,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SIDE_EFFECT],[SIDE_EFFECT],occurs in,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 18:55:58,1633311060,5/9/2015 18:55:40,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],occurs,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 19:40:16,1633342690,5/9/2015 19:39:57,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs in,n/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 20:48:01,1633365965,5/9/2015 20:47:35,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[MANIFESTATION],[MANIFESTATION],occurs,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 21:54:40,1633389567,5/9/2015 21:53:34,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],occurs,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 21:56:48,1633390410,5/9/2015 21:56:28,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[LOCATION],[LOCATION],occurs,n/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 22:00:13,1633391733,5/9/2015 21:59:56,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [NONE],"[CAUSES]
[NONE]",no,no,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 22:17:40,1633398382,5/9/2015 22:16:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SIDE_EFFECT] [CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]
[SIDE_EFFECT]",POSTOPERATIVE HYPERTENSION occurs in patients after PHEOCHROMOCYTOMA RESECTION,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 22:57:51,1633414655,5/9/2015 22:57:14,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[CAUSES],[CAUSES],occurs after,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 23:19:38,1633424008,5/9/2015 23:19:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",occurs in,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 23:38:02,1633432422,5/9/2015 23:36:43,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],occurs,n/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 23:45:45,1633435820,5/9/2015 23:45:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POSTOPERATIVE HYPERTENSION occurs in patients after PHEOCHROMOCYTOMA RESECTION,N/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/9/2015 23:55:35,1633440519,5/9/2015 23:54:13,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[SYMPTOM],[SYMPTOM],occurs in up to 50% of patients,N/A,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911594,5/10/2015 00:27:36,1633454315,5/10/2015 00:27:00,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT],"[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",occurs after,N/a,33,98,1,58,124,TWrex-cause,813536-FS1,"• According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION
717911595,5/10/2015 01:33:55,1633476566,5/10/2015 01:32:12,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION],[MANIFESTATION],PREGNANCY the placenta an endocrine gland that secretes ESTROGEN to maintain pregnancy.,n/a,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 01:45:32,1633480234,5/10/2015 01:45:09,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],PREGNANCY ESTROGEN,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 01:57:50,1633484550,5/10/2015 01:57:25,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",PREGNANCY placenta secretes ESTROGEN,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 02:01:40,1633485916,5/10/2015 01:58:48,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],During,n/a,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 02:25:53,1633494035,5/10/2015 02:24:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PART_OF] [SYMPTOM] [ASSOCIATED_WITH] [IS_A] [CAUSES],"[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",PREGNANCY placenta endocrine gland secretes ESTROGEN progesterone maintain pregnancy.,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 02:30:46,1633495578,5/10/2015 02:29:58,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PREGNANCY secretes ESTR<span id=""transmark""></span>OGEN",what,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 02:51:40,1633502343,5/10/2015 02:51:22,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],PREGNANCY ESTROGEN,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 03:01:04,1633505009,5/10/2015 03:00:37,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PREGNANCY ESTROGEN,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 03:56:31,1633519183,5/10/2015 03:56:00,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[ASSOCIATED_WITH],[ASSOCIATED_WITH],During PREGNANCY the placenta secretes ESTROGEN and progesterone,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 04:52:53,1633531304,5/10/2015 04:52:21,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[MANIFESTATION],[MANIFESTATION],PREGNANCY ESTROGEN,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 06:59:23,1633557722,5/10/2015 06:56:56,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],secretes,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 07:32:01,1633564404,5/10/2015 07:30:59,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],secretes,Associated,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 07:33:49,1633564769,5/10/2015 07:33:17,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 07:38:28,1633565579,5/10/2015 07:37:00,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[PART_OF],[PART_OF],maintain pregnancy.,n/a,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911595,5/10/2015 08:34:29,1633576581,5/10/2015 08:33:34,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PREGNANCY placenta secretes,N/A,7,66,-1,15,74,TWrex-cause,803219-FS1,During PREGNANCY the placenta is an endocrine gland that secretes ESTROGEN and progesterone to maintain pregnancy.,PREGNANCY,ESTROGEN
717911596,5/9/2015 14:23:42,1633200865,5/9/2015 14:23:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",addiction to,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 14:37:56,1633207117,5/9/2015 14:35:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],addiction to,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 14:56:47,1633215015,5/9/2015 14:56:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,Different,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:02:58,1633217850,5/9/2015 15:02:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],addiction to,n/a,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:18:52,1633224589,5/9/2015 15:17:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],COCAINE may be almost impossible to stop.,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:22:31,1633226266,5/9/2015 15:21:48,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CAUSES],[CAUSES],COCAINE ADDICTION addiction to COCAINE,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:38:46,1633233521,5/9/2015 15:38:19,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],addiction to,n/a,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:43:18,1633235611,5/9/2015 15:41:57,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],addiction,n/a,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 15:44:28,1633236380,5/9/2015 15:43:58,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COCAINE ADDICTION addiction to COCAINE,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 16:06:01,1633245876,5/9/2015 16:04:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],addiction to,causes addiction,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 16:06:25,1633246060,5/9/2015 16:05:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,COCAINE ADDICTION is caused by  COCAINE,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 16:57:53,1633266120,5/9/2015 16:57:25,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[MANIFESTATION],[MANIFESTATION],"heroin,",N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 17:01:53,1633267835,5/9/2015 17:01:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],COCAINE ADDICTION addiction to COCAINE,n/aa,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 17:59:50,1633290142,5/9/2015 17:58:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",COCAINE ADDICTION addiction COCAINE,N/A,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911596,5/9/2015 18:02:59,1633291088,5/9/2015 18:01:48,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],addiction,Addiction,0,0,1,16,7,TWrex-cause,811998-FS1,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE
717911597,5/9/2015 17:18:05,1633274132,5/9/2015 17:16:32,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],fever NEUTROPENIA,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 17:18:30,1633274290,5/9/2015 17:17:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],AMPHOTERICIN B for eliminating NEUTROPENIA,n/a,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 18:23:37,1633298644,5/9/2015 18:23:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],eliminating fever,n/a,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 18:41:31,1633305129,5/9/2015 18:41:03,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],eliminating,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 18:50:48,1633309320,5/9/2015 18:50:26,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],eliminating,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 19:32:21,1633339584,5/9/2015 19:31:47,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],eliminating fever,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 19:38:50,1633342193,5/9/2015 19:37:07,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],AMPHOTERICIN B eliminating fever and NEUTROPENIA,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 20:33:29,1633360807,5/9/2015 20:32:45,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],eliminating,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 21:44:50,1633386368,5/9/2015 21:44:15,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS],[TREATS],effective eliminating,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 21:52:55,1633388909,5/9/2015 21:52:34,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],and,n/a,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 21:54:31,1633389470,5/9/2015 21:54:08,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[SYMPTOM] [LOCATION] [CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 22:04:30,1633393366,5/9/2015 22:03:32,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],AMPHOTERICIN B eliminating NEUTROPENIA,n/a,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 22:35:12,1633405293,5/9/2015 22:33:16,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,They are both drugs.,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 22:47:01,1633410147,5/9/2015 22:45:32,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],eliminating,N/A,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911597,5/9/2015 23:23:39,1633425824,5/9/2015 23:22:42,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],eliminating,n/a,228,187,-1,238,201,TWrex-cause,800624-FS1,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B
717911598,5/10/2015 00:22:55,1633452887,5/10/2015 00:22:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],LOFFLER'S SYNDROME LOFFLER'S SYNDROME PERIPHERAL BLOOD EOSINOPHILIA,n/a,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 00:25:23,1633453657,5/10/2015 00:24:33,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[SYMPTOM],[SYMPTOM],is characterized by,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 00:47:32,1633460685,5/10/2015 00:46:56,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",characterized by,N/a,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 01:17:30,1633470988,5/10/2015 01:16:05,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM],[SYMPTOM],is characterized by PERIPHERAL BLOOD EOSINOPHILIA,n/a,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 01:40:27,1633478433,5/10/2015 01:39:37,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[SIDE_EFFECT],[SIDE_EFFECT],LOFFLER'S SYNDROME PERIPHERAL BLOOD EOSINOPHILIA,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 01:44:54,1633479907,5/10/2015 01:43:31,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],characterized by,n/a,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 01:49:45,1633481620,5/10/2015 01:49:00,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]",LOFFLER'S SYNDROME LOFFLER'S SYNDROME is characterized by PERIPHERAL BLOOD EOSINOPHILIA,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 02:11:19,1633488808,5/10/2015 02:08:45,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],"LOFFLER'S SYNDROME LOFFLER'S SYNDROME absent mild respiratory symptoms, fleeting migratory pulmonary opacities, PERIPHERAL BLOOD EOSINOPHILIA",N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 02:15:41,1633490379,5/10/2015 02:14:55,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[SYMPTOM],[SYMPTOM],"LOFFLER'S SYNDROME is characterized by PERIPHERAL BLOOD EOSINO<span id=""transmark""></span>PHILIA",me not me vork hard,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 02:46:49,1633500827,5/10/2015 02:46:29,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[TREATS],[TREATS],LOFFLER'S SYNDROME LOFFLER'S SYNDROME PERIPHERAL BLOOD EOSINOPHILIA,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 02:54:24,1633503045,5/10/2015 02:54:00,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SYMPTOM],[SYMPTOM],LOFFLER'S SYNDROME LOFFLER'S SYNDROME PERIPHERAL BLOOD EOSINOPHILIA,y/a,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 03:46:20,1633516667,5/10/2015 03:45:22,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],LOFFLER'S SYNDROME is characterized by PERIPHERAL BLOOD EOSINOPHILIA,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 04:44:04,1633529260,5/10/2015 04:43:23,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[SYMPTOM],[SYMPTOM],LOFFLER'S SYNDROME LOFFLER'S SYNDROME PERIPHERAL BLOOD EOSINOPHILIA,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 06:43:06,1633554723,5/10/2015 06:41:30,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911598,5/10/2015 07:21:00,1633562057,5/10/2015 07:19:57,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",characterized,Characterized,140,0,1,168,18,TWrex-cause,813937-FS1,"LOFFLER'S SYNDROME  LOFFLER'S SYNDROME is characterized by absent or mild respiratory symptoms, fleeting migratory pulmonary opacities, and PERIPHERAL BLOOD EOSINOPHILIA",PERIPHERAL BLOOD EOSINOPHILIA,LOFFLER'S SYNDROME
717911599,5/9/2015 13:53:35,1633187731,5/9/2015 13:53:08,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],signs,n/a,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 14:18:48,1633198634,5/9/2015 14:18:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],signs,N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 14:22:23,1633200307,5/9/2015 14:20:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],signs,N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 14:52:42,1633213343,5/9/2015 14:52:31,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",N/A,N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 14:53:33,1633213647,5/9/2015 14:52:54,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],misdiagnosed,N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 14:55:29,1633214498,5/9/2015 14:53:38,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,separate conditions,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:08:08,1633220155,5/9/2015 15:06:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"age of women scaliness, discharge, dimpling",N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:12:56,1633222103,5/9/2015 15:11:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SYMPTOM],[SYMPTOM],"ERYTHEMA scaliness, signs INFLAMMATORY BREAST CANCER",N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:32:51,1633230841,5/9/2015 15:32:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],signs,n/a,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:34:27,1633231479,5/9/2015 15:31:54,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],Physical exam misdiagnosed,n/a,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:39:13,1633233805,5/9/2015 15:38:08,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],"diagnosis Physical exam ERYTHEMA scaliness, INFLAMMATORY BREAST CANCER",N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:52:33,1633239793,5/9/2015 15:50:48,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],signs,none,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 15:52:43,1633239930,5/9/2015 15:51:13,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],signs,symptom of,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 16:15:15,1633249244,5/9/2015 16:14:00,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[SYMPTOM],[SYMPTOM],"ERYTHEMA scaliness,",N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911599,5/9/2015 16:52:02,1633263071,5/9/2015 16:50:12,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ERYTHEMA,N/A,106,150,1,113,176,TWrex-cause,812728-FS1,"The cumulative risk by age 50 is 2% and the median age of women with a new diagnosis is 64 Physical exam  ERYTHEMA scaliness, or peau d'orange signs  INFLAMMATORY BREAST CANCER can sometimes be misdiagnosed as mastitis Physical exam  New lump or nipple discharge, nipple retraction, and skin dimpling Physical exam  Axillary adenopathy  May indicate  2 disease.",ERYTHEMA,INFLAMMATORY BREAST CANCER
717911600,5/9/2015 23:06:29,1633418448,5/9/2015 23:06:06,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/9/2015 23:29:56,1633428684,5/9/2015 23:29:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],with uncontrolled,N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/9/2015 23:48:45,1633437107,5/9/2015 23:48:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],uncontrolled,n/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/9/2015 23:51:41,1633438476,5/9/2015 23:51:24,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],CROHN'S DISEASE with uncontrolled DIARRHEA,N/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 00:15:40,1633449756,5/10/2015 00:14:35,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","uncontrolled pain,",N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 00:39:56,1633458453,5/10/2015 00:38:04,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",with,N/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 00:54:06,1633463131,5/10/2015 00:53:00,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],with uncontrolled,n/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 00:59:32,1633464863,5/10/2015 00:57:28,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CROHN'S DISEASE with uncontrolled DIARRHEA,n/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 01:01:37,1633465503,5/10/2015 01:00:23,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],CROHN'S DISEASE uncontrolled DIARRHEA,N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 01:35:17,1633476869,5/10/2015 01:34:52,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","CROHN'S DISEASE DIARRHEA dehydration, severe malnutrition.",N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 01:40:20,1633478392,5/10/2015 01:39:26,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",patients with CROHN'S DISEASE with uncontrolled DIARRHEA,N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 02:03:55,1633486502,5/10/2015 02:02:44,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[SIDE_EFFECT],[SIDE_EFFECT],"uncontrolled DIAR<span id=""transmark""></span>RHEA",I haven't,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 02:43:49,1633499827,5/10/2015 02:43:11,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[CAUSES],[CAUSES],"CROHN'S DISEASE DIARRHEA dehydration, malnutrition.",N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 02:47:41,1633501074,5/10/2015 02:46:49,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[TREATS],[TREATS],"CROHN'S DISEASE DIARRHEA uncontrolled dehydration, malnutrition.",y/a,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911600,5/10/2015 02:56:35,1633503658,5/10/2015 02:54:34,false,clixsense,1,29490692,USA,NY,Hilton,66.66.96.233,[SYMPTOM],[SYMPTOM],CROHN'S DISEASE with uncontrolled DIARRHEA,N/A,68,34,1,75,49,TWrex-cause,813383-FS1,"C]  5.1 Hospitalize patients with CROHN'S DISEASE with uncontrolled DIARRHEA uncontrolled pain, dehydration, or severe malnutrition.",DIARRHEA,CROHN'S DISEASE
717911601,5/9/2015 14:23:07,1633200663,5/9/2015 14:22:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],or,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 14:35:33,1633206166,5/9/2015 14:32:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 14:54:49,1633214235,5/9/2015 14:54:40,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",N/A,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 14:56:22,1633214854,5/9/2015 14:56:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],May cause,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:02:19,1633217526,5/9/2015 15:00:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:17:31,1633224025,5/9/2015 15:16:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"(SLE May cause SLE (e.g., glomerulonephritis)",N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:21:46,1633225871,5/9/2015 15:21:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[CAUSES],[CAUSES],ERYTHEMATOSUS (SLE May cause RHEUMATOID ARTHRITIS,N /A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:38:18,1633233302,5/9/2015 15:37:23,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],May cause,n/a,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:41:56,1633234996,5/9/2015 15:40:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 15:43:57,1633236063,5/9/2015 15:43:10,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],ERYTHEMATOSUS or RHEUMATOID ARTHRITIS,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 16:04:52,1633245461,5/9/2015 16:03:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],May cause,may cause,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 16:05:20,1633245638,5/9/2015 16:03:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 16:57:19,1633265883,5/9/2015 16:54:46,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],RHEUMATOID ARTHRITIS,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 17:01:13,1633267457,5/9/2015 17:00:27,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ERYTHEMATOSUS or RHEUMATOID ARTHRITIS,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911601,5/9/2015 17:58:15,1633289510,5/9/2015 17:56:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],Warnings/Precautions ERYTHEMATOSUS (SLE May cause SLE or RHEUMATOID ARTHRITIS,N/A,122,58,1,141,76,TWrex-cause,814230-FS1,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE
717911602,5/9/2015 13:55:20,1633188553,5/9/2015 13:53:36,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy for,n/a,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 14:19:10,1633198798,5/9/2015 14:18:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 14:23:14,1633200714,5/9/2015 14:22:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],salvage therapy,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 14:53:03,1633213474,5/9/2015 14:52:43,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[NONE] [PART_OF],"[PART_OF]
[NONE]",N/A,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 14:53:49,1633213785,5/9/2015 14:53:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],as therapy for chronic,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 14:56:07,1633214758,5/9/2015 14:55:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy for,n/a,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:09:39,1633220869,5/9/2015 15:08:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],salvage therapy chronic GRAFT VERSUS HOST DISEASE,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:13:40,1633222449,5/9/2015 15:12:57,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:33:12,1633230980,5/9/2015 15:32:52,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],salvage therapy,n/a,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:34:45,1633231649,5/9/2015 15:34:29,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],salvage therapy,n/a,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:39:39,1633234052,5/9/2015 15:39:15,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:54:00,1633240492,5/9/2015 15:52:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,used in therapy,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 15:54:19,1633240614,5/9/2015 15:52:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,THALIDOMIDE is a therapy for GRAFT VERSUS HOST DISEASE,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 16:16:00,1633249521,5/9/2015 16:15:17,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],salvage therapy,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911602,5/9/2015 16:35:51,1633257132,5/9/2015 16:33:33,false,instagc,1.0,22981457,CAN,ON,Kitchener,174.113.174.129,[TREATS],[TREATS],therapy,N/A,79,36,-1,103,47,TWrex-cause,804039-FS1,"Parker PM, Chao N, Nademanee A et alTHALIDOMIDE as salvage therapy for chronic GRAFT VERSUS HOST DISEASE",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
717911603,5/10/2015 00:21:30,1633452334,5/10/2015 00:20:48,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],in the treatment of,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 00:21:35,1633452350,5/10/2015 00:21:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY treatment GERIATRIC ANOREXIA/CACHEXIA,n/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 00:44:53,1633459905,5/10/2015 00:43:55,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 01:09:36,1633468258,5/10/2015 01:06:58,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA,n/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 01:11:13,1633468786,5/10/2015 01:10:01,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY treatment GERIATRIC ANOREXIA/CACHEXIA,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 01:29:26,1633474967,5/10/2015 01:27:42,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],the treatment,n/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 01:38:35,1633477873,5/10/2015 01:38:03,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY GERIATRIC ANOREXIA/CACHEXIA,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 01:44:08,1633479660,5/10/2015 01:43:12,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 02:12:42,1633489346,5/10/2015 02:12:04,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"MEGESTROL ACETATE SUSPENSION THERAPY treatment of GERIATRIC ANO<span id=""transmark""></span>REXIA/CACHEXIA",I haven't,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 02:45:46,1633500490,5/10/2015 02:45:26,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[SYMPTOM],[SYMPTOM],MEGESTROL ACETATE SUSPENSION THERAPY GERIATRIC ANOREXIA/CACHEXIA,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 02:52:10,1633502524,5/10/2015 02:51:38,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[SYMPTOM],[SYMPTOM],MEGESTROL ACETATE SUSPENSION THERAPY GERIATRIC ANOREXIA/CACHEXIA,y/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 03:05:55,1633506415,5/10/2015 03:05:15,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],in the treatment of,n/a,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 03:43:55,1633516081,5/10/2015 03:43:06,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[NONE],[NONE],N/A,No relation,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 04:41:58,1633528736,5/10/2015 04:39:47,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[TREATS],[TREATS],MEGESTROL ACETATE SUSPENSION THERAPY GERIATRIC ANOREXIA/CACHEXIA,N/A,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911603,5/10/2015 04:51:54,1633531067,5/10/2015 04:50:38,false,neodev,1,20233773,USA,OH,Columbus,216.185.58.230,[TREATS],[TREATS],treatment,MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA,127,70,-1,153,106,TWrex-cause,800874-FS1,"1]  Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, et al. MEGESTROL ACETATE SUSPENSION THERAPY in the treatment of GERIATRIC ANOREXIA/CACHEXIA in nursing home patients.",GERIATRIC ANOREXIA/CACHEXIA,MEGESTROL ACETATE SUSPENSION THERAPY
717911604,5/9/2015 13:50:26,1633186508,5/9/2015 13:49:18,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[NONE],[NONE],n/a,not related,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:13:58,1633196592,5/9/2015 14:12:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],can occur,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:14:50,1633196930,5/9/2015 14:14:11,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],extremely common,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:43:47,1633209521,5/9/2015 14:42:34,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[OTHER],[OTHER],HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:50:57,1633212637,5/9/2015 14:50:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,Different diseases that have no relation,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:51:05,1633212679,5/9/2015 14:50:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,two separate conditions,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:51:07,1633212687,5/9/2015 14:50:56,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",N/A,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 14:58:41,1633215796,5/9/2015 14:57:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],GENITAL WARTS monogamous relationship.,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:04:44,1633218701,5/9/2015 15:03:48,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[PREVENTS] [ASSOCIATED_WITH],"[PREVENTS]
[ASSOCIATED_WITH]",HPV INFECTION is common and GENITAL WARTS,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:27:10,1633228268,5/9/2015 15:26:17,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[NONE],[NONE],N/a,No obvious relation between the two things.,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:28:55,1633229076,5/9/2015 15:27:23,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],and,n/a,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:30:12,1633229593,5/9/2015 15:29:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],and,n/a,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:34:00,1633231309,5/9/2015 15:33:23,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,They are two separate STIs that she is being informed about,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:42:18,1633235125,5/9/2015 15:39:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,occur when sexually active even when monogamous,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911604,5/9/2015 15:45:36,1633236898,5/9/2015 15:43:21,false,prodege,1.0,27934334,GBR,A7,Birmingham,86.143.148.75,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",can occur,N/A,93,21,1,105,34,TWrex-cause,812579-FS1,She is informed that HPV INFECTION is extremely common among sexually active adults and that GENITAL WARTS can occur in a monogamous relationship.,GENITAL WARTS,HPV INFECTION
717911605,5/9/2015 18:28:06,1633300290,5/9/2015 18:27:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],improved,n/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 18:51:51,1633309620,5/9/2015 18:51:20,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],improved control,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 18:56:52,1633311328,5/9/2015 18:56:35,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],improved,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 19:41:29,1633343130,5/9/2015 19:41:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],improved,n/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 20:50:35,1633366826,5/9/2015 20:50:03,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],improved,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 21:55:51,1633389998,5/9/2015 21:55:23,false,neodev,1,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],showed improved,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 21:57:36,1633390693,5/9/2015 21:57:08,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],improved,n/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 22:00:51,1633392008,5/9/2015 22:00:37,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 22:19:21,1633398959,5/9/2015 22:18:57,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],MONTELUKAST improved ASTHMA,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 22:59:44,1633415487,5/9/2015 22:58:59,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],improved,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 23:23:39,1633425823,5/9/2015 23:22:32,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],improved better than,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 23:39:47,1633433206,5/9/2015 23:38:55,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],improved,n/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 23:46:51,1633436286,5/9/2015 23:46:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],MONTELUKAST plus budesonide improved ASTHMA,N/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/9/2015 23:59:15,1633442305,5/9/2015 23:58:15,false,points4rewards,1,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],improved ASTHMA control better,N/A,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911605,5/10/2015 00:28:32,1633454756,5/10/2015 00:27:37,false,getpaid,1,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],control,N/a,99,62,-1,104,73,TWrex-cause,804836-FS1,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST
717911606,5/10/2015 00:24:02,1633453264,5/10/2015 00:23:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],GALLIUM NITRATE treatment CANCER RELATED HYPERCALCEMIA,n/a,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 00:28:23,1633454717,5/10/2015 00:27:49,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[TREATS],[TREATS],for acute treatment,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 01:21:31,1633472436,5/10/2015 01:20:25,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],for acute treatment of,n/a,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 01:42:30,1633479112,5/10/2015 01:42:05,false,elite,1,31848723,CAN,BC,Vancouver,162.245.145.108,[TREATS],[TREATS],GALLIUM NITRATE CANCER RELATED HYPERCALCEMIA,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 01:49:40,1633481610,5/10/2015 01:48:40,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],acute treatment of,n/a,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 01:54:34,1633483437,5/10/2015 01:54:11,false,prodege,1,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 02:15:26,1633490314,5/10/2015 02:14:44,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],GALLIUM NITRATE acute treatment CANCER RELATED HYPERCALCEMIA,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 02:21:24,1633492389,5/10/2015 02:20:38,false,clixsense,1,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCA<span id=""transmark""></span>LCEMIA",gallium rulez,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 02:49:24,1633501640,5/10/2015 02:49:04,false,elite,1,32306791,USA,TX,Dallas,69.162.75.20,[TREATS],[TREATS],GALLIUM NITRATE CANCER RELATED HYPERCALCEMIA,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 02:56:03,1633503521,5/10/2015 02:55:38,false,neodev,1,32087449,USA,TX,Dallas,64.31.33.166,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GALLIUM NITRATE CANCER RELATED HYPERCALCEMIA,y/a,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 03:50:22,1633517645,5/10/2015 03:49:09,false,clixsense,1,13783237,USA,CA,San Diego,76.93.186.41,[OTHER],[OTHER],GALLIUM NITRATE for treatment of HYPERCALCEMIA,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 04:47:45,1633530108,5/10/2015 04:46:15,false,gptking,1,31799065,USA,IL,Marion,50.45.50.180,[OTHER],[OTHER],GALLIUM NITRATE CANCER RELATED HYPERCALCEMIA,cancer related hypercalcemia is treated with gallium nitrate,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 06:47:32,1633555660,5/10/2015 06:46:59,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 07:25:10,1633562963,5/10/2015 07:23:58,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treatment,Treated with,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911606,5/10/2015 07:29:33,1633563946,5/10/2015 07:28:48,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,39,0,-1,66,15,TWrex-cause,800755-FS1,GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA,CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
717911607,5/9/2015 18:26:18,1633299643,5/9/2015 18:25:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],improved survival,n/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 18:47:46,1633308039,5/9/2015 18:46:50,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],proarrhythmic properties,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 18:54:49,1633310628,5/9/2015 18:54:19,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],improved,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 19:38:57,1633342242,5/9/2015 19:37:20,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],survival,n/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 20:43:21,1633364329,5/9/2015 20:42:34,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],threatening,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 21:51:52,1633388517,5/9/2015 21:51:25,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[CAUSES],[CAUSES],evidence improved,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 21:55:54,1633390008,5/9/2015 21:55:35,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],procainamide,n/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 21:59:11,1633391368,5/9/2015 21:58:02,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 22:15:02,1633397182,5/9/2015 22:14:03,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,The text mentions lack of evidence between treatment and condition.,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 22:56:09,1633414034,5/9/2015 22:54:11,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],for life threatening,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 23:17:52,1633423295,5/9/2015 23:17:20,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],DRUG,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 23:35:11,1633431083,5/9/2015 23:34:35,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DRUG,n/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 23:43:11,1633434619,5/9/2015 23:42:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],improved ANTIARRHYTHMIC VENTRICULAR ARRHYTHMIAS,N/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/9/2015 23:50:09,1633437835,5/9/2015 23:48:23,false,points4rewards,1.0,28703583,USA,"","",97.73.94.14,[CONTRAINDICATES],[CONTRAINDICATES],lack of evidence,N/A,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911607,5/10/2015 00:24:40,1633453481,5/10/2015 00:23:41,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],for life threatening,N/a,170,108,-1,192,127,TWrex-cause,804716-FS1,135 •  Because of procainamide's proarrhythmic properties and lack of evidence of improved survival for any ANTIARRHYTHMIC DRUG reserve procainamide for life threatening VENTRICULAR ARRHYTHMIAS,VENTRICULAR ARRHYTHMIAS,ANTIARRHYTHMIC DRUG
717911608,5/10/2015 01:31:08,1633475579,5/10/2015 01:29:04,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 01:44:41,1633479829,5/10/2015 01:44:16,false,elite,1.0,31848723,CAN,BC,Vancouver,162.245.145.108,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COWDEN SYNDROME COWDEN SYNDROME FACIAL TRICHILEMMOMAS,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 01:56:44,1633484222,5/10/2015 01:56:08,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",COWDEN SYNDROME COWDEN SYNDROME characterized by FACIAL TRICHILEMMOMAS,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 01:56:49,1633484251,5/10/2015 01:55:23,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],characterized by,n/a,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 02:22:11,1633492701,5/10/2015 02:19:54,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","COWDEN SYNDROME COWDEN SYNDROME characterized FACIAL TRICHILEMMOMAS acral fibromas associated increased risk cancer breast, thyroid, gastrointestinal tract.",N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 02:27:13,1633494475,5/10/2015 02:26:34,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"COWDEN SYNDROME COWDEN SYNDROME is characterized by FACIAL TRIC<span id=""transmark""></span>HILEMMOMAS",i have not,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 02:50:59,1633502131,5/10/2015 02:50:36,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COWDEN SYNDROME COWDEN SYNDROME FACIAL,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 02:59:53,1633504705,5/10/2015 02:59:10,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.166,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COWDEN SYNDROME FACIAL TRICHILEMMOMAS,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 03:54:32,1633518639,5/10/2015 03:53:44,false,clixsense,1.0,13783237,USA,CA,San Diego,76.93.186.41,[MANIFESTATION],[MANIFESTATION],COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 04:51:40,1633530982,5/10/2015 04:51:16,false,gptking,1.0,31799065,USA,IL,Marion,50.45.50.180,[SYMPTOM],[SYMPTOM],COWDEN SYNDROME FACIAL TRICHILEMMOMAS,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 06:55:26,1633557109,5/10/2015 06:54:15,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],characterized,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 07:29:27,1633563898,5/10/2015 07:28:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],characterized,Symptom,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 07:32:36,1633564547,5/10/2015 07:31:36,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,n/a,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 07:35:57,1633565184,5/10/2015 07:34:57,false,instagc,1.0,22535866,GBR,M2,Solihull,80.195.193.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],characterized,n/a,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911608,5/10/2015 08:05:16,1633570508,5/10/2015 08:04:37,false,prodege,1,27934334,GBR,C7,Coventry,109.150.225.5,[MANIFESTATION],[MANIFESTATION],is characterized by,N/A,53,0,1,73,15,TWrex-cause,813308-FS1,"COWDEN SYNDROME  COWDEN SYNDROME is characterized by FACIAL TRICHILEMMOMAS and acral fibromas and is associated with an increased risk of cancer of the breast, thyroid, and gastrointestinal tract.",FACIAL TRICHILEMMOMAS,COWDEN SYNDROME
717911609,5/9/2015 14:25:42,1633201905,5/9/2015 14:25:07,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],may require supplemental,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 14:45:15,1633210160,5/9/2015 14:43:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],may require,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 14:58:35,1633215769,5/9/2015 14:58:17,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],may require,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 15:06:21,1633219381,5/9/2015 15:06:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],may require,n/a,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 15:23:43,1633226650,5/9/2015 15:22:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Risk severe NONCARDIOGENIC PULMONARY OXYGEN,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 15:26:49,1633228115,5/9/2015 15:25:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[TREATS],[TREATS],NONCARDIOGENIC PULMONARY EDEMA may require OXYGEN,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 15:41:47,1633234941,5/9/2015 15:41:24,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],may require,n/a,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 15:48:02,1633238024,5/9/2015 15:46:22,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],may require supplemental,n/a,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 16:11:09,1633247667,5/9/2015 16:09:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],may require,used to treat,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 16:15:40,1633249365,5/9/2015 16:14:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],require,none,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 17:00:26,1633267072,5/9/2015 16:59:36,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],"dyspnea, wheezing,",N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 17:04:59,1633269089,5/9/2015 17:04:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],NONCARDIOGENIC PULMONARY EDEMA may require OXYGEN,n/a,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 18:03:38,1633291294,5/9/2015 18:02:45,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],NONCARDIOGENIC PULMONARY EDEMA may require supplemental OXYGEN,N/A,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 18:06:02,1633292187,5/9/2015 18:03:53,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],support.,Suppoprt,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911609,5/9/2015 18:18:41,1633296780,5/9/2015 18:18:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],require supplemental,n/a,128,219,-1,157,225,TWrex-cause,803906-FS1,"Risk of severe and rarely fatal adverse respiratory effects (e.g., dyspnea, wheezing, pulmonary infiltrates, pleural effusions, NONCARDIOGENIC PULMONARY EDEMA pulmonary insufficiency, hypoxia); may require supplemental OXYGEN or ventilatory support.",NONCARDIOGENIC PULMONARY EDEMA,OXYGEN
717911610,5/9/2015 13:45:14,1633184443,5/9/2015 13:44:43,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],such as,n/a,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 13:46:02,1633184806,5/9/2015 13:45:16,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],such as,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 13:52:45,1633187363,5/9/2015 13:51:01,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],such as,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:12:21,1633195967,5/9/2015 14:11:33,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A] [SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]",such as,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:40:12,1633208053,5/9/2015 14:38:59,false,clixsense,1.0,16498372,CAN,ON,Toronto,76.10.131.218,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection;,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:40:25,1633208129,5/9/2015 14:39:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,none,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:48:51,1633211780,5/9/2015 14:47:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],such as,n/a,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:49:12,1633211945,5/9/2015 14:48:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:50:23,1633212403,5/9/2015 14:49:50,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[CAUSES] [NONE],"[CAUSES]
[NONE]",N/A,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:52:32,1633213288,5/9/2015 14:51:23,false,instagc,1,19740138,CAN,"","",50.69.96.237,[MANIFESTATION],[MANIFESTATION],such as,n/a,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 14:54:03,1633213861,5/9/2015 14:51:30,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],VIRAL INFECTIONS such,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 15:01:13,1633217094,5/9/2015 14:59:31,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[IS_A],[IS_A],VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 15:23:58,1633226749,5/9/2015 15:23:01,false,prodege,1.0,22031444,GBR,"","",80.44.147.241,[IS_A],[IS_A],such as,N/a,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 15:25:28,1633227446,5/9/2015 15:24:40,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],such as,N/A,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911610,5/9/2015 15:28:22,1633228815,5/9/2015 15:26:27,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],such as,n/a,54,79,-1,69,138,TWrex-cause,803230-FS1,"Acquired lymphocytopenia can be seen in patients with VIRAL INFECTIONS such as HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL virus infection; in patients with certain bacterial infections, such as typhoid fever, pneumonia, sepsis, and tuberculosis; and in patients with aplastic anemia, autoimmune diseases, Hodgkin disease, sarcoidosis, renal failure, protein losing enteropathies, and chylous ascites.",VIRAL INFECTIONS,HIV INFECTION HEPATITIS INFLUENZA AND RESPIRATORY SYNCYTIAL
717911611,5/9/2015 17:18:25,1633274248,5/9/2015 17:18:06,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],QUINIDINE GLUCONATE,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 17:19:24,1633274624,5/9/2015 17:18:32,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[MANIFESTATION],[MANIFESTATION],VENTRICULAR TACHYCARDIA have occurred in patients receiving QUINIDINE GLUCONATE,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 18:24:01,1633298828,5/9/2015 18:23:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],occurred occasionally patients receiving,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 18:42:36,1633305593,5/9/2015 18:41:32,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SIDE_EFFECT],[SIDE_EFFECT],occurred occasionally,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 18:51:09,1633309429,5/9/2015 18:50:49,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],have occurred,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 19:33:03,1633339854,5/9/2015 19:32:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SIDE_EFFECT],[SIDE_EFFECT],occurred occasionally,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 19:39:56,1633342617,5/9/2015 19:38:51,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],hypotension VENTRICULAR TACHYCARDIA have occurred occasionally patients receiving IV QUINIDINE GLUCONATE treatment of Plasmodium falciparum malaria.,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 20:34:57,1633361361,5/9/2015 20:33:29,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS] [OTHER],"[TREATS]
[OTHER]",treatment,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 21:45:27,1633386597,5/9/2015 21:44:51,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","has not occurred,",N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 21:53:30,1633389086,5/9/2015 21:52:56,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[SIDE_EFFECT],[SIDE_EFFECT],occurred,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 21:55:08,1633389766,5/9/2015 21:54:34,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 22:05:49,1633393831,5/9/2015 22:04:31,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SIDE_EFFECT],[SIDE_EFFECT],VENTRICULAR TACHYCARDIA occurred occasionally in patients receiving QUINIDINE GLUCONATE,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 22:47:57,1633410430,5/9/2015 22:47:02,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[SYMPTOM],[SYMPTOM],occurred,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 22:49:25,1633411064,5/9/2015 22:48:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SIDE_EFFECT],[SIDE_EFFECT],have occurred occasionally,N/A,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911611,5/9/2015 23:27:51,1633427813,5/9/2015 23:26:59,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurred,n/a,230,306,-1,252,325,TWrex-cause,804683-FS1,"b  While substantial cardiovascular toxicity generally has not occurred, ECG changes, including prolonged QT interval, widened QRS complex, and flattened T waves (without dysrhythmia), have occurred frequently and hypotension and VENTRICULAR TACHYCARDIA have occurred occasionally in patients receiving IV QUINIDINE GLUCONATE for the treatment of  Plasmodium falciparum  malaria.",VENTRICULAR TACHYCARDIA,QUINIDINE GLUCONATE
717911612,5/9/2015 16:23:21,1633252162,5/9/2015 16:21:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],of the,occurs there,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 16:29:12,1633254679,5/9/2015 16:27:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,CENTRAL NERVOUS SYSTEM  exhibits   DISEASES,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 17:11:59,1633271463,5/9/2015 17:11:28,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],Neuromuscular,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 17:12:21,1633271649,5/9/2015 17:11:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[MANIFESTATION],[MANIFESTATION],DISEASES of the CENTRAL NERVOUS SYSTEM,n/a,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 18:20:54,1633297592,5/9/2015 18:20:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of the,n/a,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 18:37:02,1633303295,5/9/2015 18:35:49,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[SYMPTOM],[SYMPTOM],urinary incontinence,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 18:48:14,1633308228,5/9/2015 18:47:37,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DISEASES of,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 19:19:45,1633327867,5/9/2015 19:18:49,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],of the,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 19:28:31,1633338071,5/9/2015 19:27:10,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[OTHER],[OTHER],of the,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 19:32:26,1633339614,5/9/2015 19:30:47,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DISEASES of the CENTRAL NERVOUS SYSTEM,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 20:26:44,1633358569,5/9/2015 20:26:12,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",identifies patients,N/A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 21:35:45,1633383249,5/9/2015 21:34:40,false,neodev,1.0,28448810,USA,VA,Manassas,98.218.212.74,[NONE],[NONE],N/A,I don't see the relation between those terms.,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 21:49:56,1633387909,5/9/2015 21:49:19,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[LOCATION],[LOCATION],of,n/a,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 21:51:45,1633388491,5/9/2015 21:50:23,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.247,[MANIFESTATION] [LOCATION] [NONE],"[LOCATION]
[MANIFESTATION]
[NONE]",no,no,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911612,5/9/2015 21:57:55,1633390806,5/9/2015 21:56:30,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],DISEASES of the CENTRAL NERVOUS SYSTEM,N?A,88,72,-1,109,80,TWrex-cause,802385-FS1,"Neuromuscular examination identifies patients with impaired mobility or DISEASES of the CENTRAL NERVOUS SYSTEM that predispose to urinary incontinence (e.g., stroke, Parkinson disease, or dementia.",CENTRAL NERVOUS SYSTEM,DISEASES
717911613,5/9/2015 14:27:39,1633202602,5/9/2015 14:27:03,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 14:52:14,1633213132,5/9/2015 14:51:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],after treatment with,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 14:59:45,1633216493,5/9/2015 14:59:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 15:08:46,1633220513,5/9/2015 15:08:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],after treatment with,n/a,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 15:28:41,1633228936,5/9/2015 15:27:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],Early reversal right ventricular dysfunction patients with ACUTE PULMONARY EMBOLISM,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 15:30:55,1633229909,5/9/2015 15:29:59,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[SIDE_EFFECT],[SIDE_EFFECT],ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 15:45:04,1633236721,5/9/2015 15:44:42,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment with,n/a,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 15:54:42,1633240774,5/9/2015 15:52:31,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment with,n/a,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 16:16:58,1633249957,5/9/2015 16:15:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment with,used to treat,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 16:21:59,1633251604,5/9/2015 16:20:53,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ACUTE PULMONARY EMBOLISM is treated with TISSUE PLASMINOGEN ACTIVATOR,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 17:07:08,1633269981,5/9/2015 17:05:17,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[PREVENTS],[PREVENTS],dysfunction,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 17:09:25,1633270749,5/9/2015 17:08:28,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR,n/a,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 18:07:11,1633292590,5/9/2015 18:06:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 18:19:06,1633296948,5/9/2015 18:18:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment with,n/a,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911613,5/9/2015 18:24:40,1633299047,5/9/2015 18:24:11,false,elite,1.0,30064988,GBR,"","",89.241.94.221,[TREATS],[TREATS],reversal,N/A,98,147,-1,121,175,TWrex-cause,800484-FS1,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR
717911614,5/9/2015 14:21:21,1633199822,5/9/2015 14:20:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],reduces hospitalization,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 14:27:52,1633202696,5/9/2015 14:25:31,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduces hospitalization from,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 14:54:15,1633213959,5/9/2015 14:54:02,false,neodev,1.0,31789301,USA,VA,Mclean,63.141.204.56,[CAUSES] [NONE],"[CAUSES]
[NONE]",N/A,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 14:55:05,1633214326,5/9/2015 14:54:44,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],reduces hospitalization from,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 14:58:14,1633215664,5/9/2015 14:57:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],reduces hospitalization from,n/a,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:14:06,1633222600,5/9/2015 15:13:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],reduces hospitalization,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:19:15,1633224730,5/9/2015 15:18:38,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.150.108,[PREVENTS],[PREVENTS],reduces hospitalization,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:36:29,1633232424,5/9/2015 15:36:00,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],reduces hospitalization,n/a,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:38:37,1633233448,5/9/2015 15:38:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],reduces hospitalization,n/a,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:41:22,1633234765,5/9/2015 15:41:05,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 15:59:55,1633243338,5/9/2015 15:58:53,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],reduces hospitalization,none,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 16:00:44,1633243767,5/9/2015 15:58:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],reduces hospitalization,treats,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 16:18:31,1633250569,5/9/2015 16:18:04,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],reduces,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 16:50:09,1633262176,5/9/2015 16:48:23,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],MONOCLONAL,n/a,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
717911614,5/9/2015 16:59:40,1633266803,5/9/2015 16:58:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION,N/A,102,25,1,138,72,TWrex-cause,810684-FS1,"Palivizumab, a humanized RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY reduces hospitalization from RESPIRATORY SYNCYTIAL VIRUS INFECTION in high risk infants.",RESPIRATORY SYNCYTIAL VIRUS INFECTION,RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL ANTIBODY
